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Abstract 
Heart Failure is a growing and costly problem in the United States.  There have been 
advancements in medical therapy, but unfortunately patients continue to have frequent 
exacerbations and hospital readmissions.  The reason for this may be inadequate Heart 
Failure self-care, which is the most important aspect of disease management.  Literature 
strongly encourages self-care, but there is minimal research focusing on the use of a 
Heart Failure diary.  The study was a one group pretest/posttest design.  The intervention 
included individualized education, provision of the Heart Failure Diary, and weekly 
follow-up for a total of four weeks.  The Heart Failure Diary was developed specifically 
for this study for recording daily self-care maintenance activities which includes weight 
monitoring, fluid intake, salt intake, swelling, shortness of breath, and medication 
adherence.  In order to determine the effects of using the diary on self-care and quality of 
life, the Self-Care of Heart Failure Index (SCHFI) and Minnesota Living with Heart 
Failure Questionnaire (MLHFQ) responses were compared pre and post intervention.  
The difference between the SCHFI pretest-posttest scores demonstrated a non-significant 
improvement in self-care maintenance, n = 14, 2.616 (12.942), SE = 3.459, p = .463, t = -
.756, 95% CI [-10.089, 4.856].  The difference between the MLHFQ pretest-posttest 
scores demonstrated a non-significant improvement in quality of life, n = 14, -5.500 
(18.851), SE = 5.038, p = .295, t = 1.092, 95% CI [-5.384, 16.384].  The effect size of the 
SCHFI, d = .20, and the MLHFQ, d = .29, are both small and most likely due to the small 
sample size.  The study concluded that using the diary did not have a statistically 
significant effect on the self-care or quality of life of these patients with heart failure.      
 
  
 
 
 
Chapter One: Introduction     
Heart failure (HF) is a common and increasing health problem worldwide.  It is a 
chronic illness that is associated with poor quality of life (QOL), frequent hospital 
readmissions, and early death (Riegel & Dickson, 2008).   Negative outcomes may be 
averted through adherence to recommended treatment and recognizing worsening 
symptoms.  Self-care is essential for improving QOL for those with HF.  The diagnosis of 
heart failure requires a change of lifestyle in order to adhere to treatment.  The change of 
lifestyle involves daily weight monitoring, decreasing sodium intake, reducing fluid 
intake, continuing exercise as tolerated, recognizing symptoms, administering 
medications as prescribed, and following-up with health providers regularly.  Self-care is 
the sole responsibility of patients, although the support of family members and providers’ 
provides positive reinforcement and guidance.     
Nurses play a major role in engaging and encouraging patients in performing self-
care.  In most health care settings, nurses provide the majority of patient education. 
Patient education is of great importance in order to assist patients in taking control and 
adapting to their diagnosis of heart failure (Washburn & Hornberger, 2008).  Heart 
failure clinics, a setting that provides frequent patient-nurse interaction, have proven to 
reduce hospitalizations (Eastwood, Travis, Morgenstern, & Donaho, 2007). Nurses 
interact with patients to assess their needs, intervene appropriately, and evaluate their 
outcome.  Self-care activities may be demanding for some patients and therefore may 
benefit from the support and encouragement nurses can provide.  The self-care 
collaboration of patients with nurses is important for illness adaptation, self-care success, 
and quality of life improvement. 
The American Heart Association (AHA) recommended HF self-care behaviors 
include symptom monitoring (i.e., weight changes, shortness of breath, and swelling), 
sodium restriction, and medication adherence (Riegel, Lee, Dickson, & Carlson , 2009).  
These recommended behaviors were the focus of this study’s HF health diary entries. 
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Problem and Purpose 
According to Eastwood et al. (2007) heart failure programs commonly encourage 
patients to record their daily weight and symptoms; but lack in description, 
demonstration, and reinforcement.  Literature strongly encourages self-care, but there is 
minimal research focusing on the use of a HF health diary (Eastwood et al., 2007).  Self-
monitoring may improve body awareness, communication with health professionals, and 
self-efficacy in controlling heart failure.  Diaries may be useful for nurses in assessing, 
promoting, and evaluating self-care behaviors. The purpose of this study is to determine 
the effects of using a HF diary on self-care and QOL.  The study hypothesizes that the 
use of a health diary will improve self-care and quality of life, in patients with heart 
failure.  
Conceptual Framework 
Heart Failure Self-care.  Riegel & Dickson’s (2008) article “A Situation-
Specific Theory of Heart Failure Self-Care” provides a description and visual 
presentation of the HF self-care process based on the natural decision making (NDM) 
framework.  The four characteristics of NDM include: “(1) focusing on process rather 
than outcome, (2) using decision rules that match the situation and the action, (3) letting 
context influence decision-making, (4) basing practical decisions on the empiric 
information available at the moment” (Riegel et al., 2004, p. 351).  It recognizes HF self-
care as a process that is initiated by self-care maintenance, transitions into action with 
self-care management, and influenced by self-care confidence.   
According to Riegel and Dickson’s (2008) theoretical model, the HF self-care 
process is categorized into stages (see Figure 1). The first (i.e., symptom monitoring and 
treatment adherence) and second (i.e., symptom recognition) stages constitute self-care 
maintenance.  The third (i.e., symptom evaluation), fourth (i.e., treatment 
implementation), and fifth (i.e., treatment evaluation) stages constitute self-care 
management.  The theoretical model also illustrates the context of self-care confidence 
and its role in the overall self-care process.  The modifying effect of self-care confidence 
on outcomes is two-fold, as a mediator or moderator (Riegel & Dickson, 2008).  
Successful maintenance and management may improve confidence and vice versa. 
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Figure 1.  The theoretical model depicting the self-care process, for patients with Heart 
Failure, with self-care maintenance as the study’s focus.  Adapted from “A situation-
specific theory of heart failure self-care,” by B. Riegel & V. Y. Dickson, 2008, Journal of 
Cardiovascular Nursing, 23, p.192. 
 
The situation-specific theory of heart failure self-care is an applicable framework 
to integrate into this study.  The theory’s conceptual design is congruent with this study’s 
focus on self-care maintenance.  The theory assumes and/or predicts that self-care 
maintenance improves self-care management.  In “Psychometric Testing of the Self-care 
of Heart Failure Index” the authors hypothesized that the patients with inadequate 
symptom recognition were unsuccessful in proceeding to the subsequent steps of self-care 
management.  The treatment initiation and treatment evaluation scores were significantly 
higher in patients that recognized symptoms quickly (Riegel & Dickson, 2008).  
Symptom recognition is essential in self-care management.  
Quality of Life.  A major goal of nursing is promoting self-care and improving 
quality of life (QOL). In 1985, Padilla & Grant developed a QOL model that identifies 
independent nursing process interventions as an individual concept (see Figure 2) 
(Bredow, Peterson, & Sandau, 2009, Chapter 13, p. 279).  The model recognizes self-care 
promotion as a variable of the independent nursing process.  Visually, it represents the 
influence self-care promotion has on perceived self-care ability.  Subsequently, perceived 
self-care ability effects QOL dimensions, specifically diagnosis/treatment response and 
physical wellbeing.  The model was originally developed from cancer research, however 
its self-care conceptual component may make it applicable to HF as well.   
Self-Care of Heart Failure Model 
Self-care Maintenance 
Self-care Confidence 
Stage 2 
Symptom  
Recognition 
Stage 3 
Symptom  
Evaluation 
Stage 4 
Treatment  
Implementation 
Stage 5 
Treatment  
Evaluation 
Self-care Management 
Stage 1 
Symptom monitoring and 
treatment adherence 
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Figure 2.  Padilla & Grants’ theoretical model recognizes self-care promotion, as a 
nursing intervention that influences a patient’s overall quality of life.  Adapted from 
“Health-Related Quality of Life,” by T. S. Bredow, S. J. Peterson, and K. E. Sandau, 
2009, Middle Range Theories: Application to Nursing Research, Peterson, S. J. & 
Bredow, T. S. (Eds.), Chapter 13, p. 279. 
 
 
Definition of Terms 
 Heart Failure.  Heart failure is characterized by two factors (a) a 
pathophysiological state in which inadequate cardiac output is unable to meet metabolic 
demands of tissues or (b) elevated intracardiac pressures deliver adequate cardiac output 
but can precipitate systemic or vascular congestion (DiSalvo, 2005).   
 Self-care.  Self-care is defined by Riegel and Dickson (2008) as “a naturalistic 
decision-making process involving the choice of behaviors that maintain physiologic 
stability (maintenance) and the response to symptoms when they occur (management)” 
(p. 190).  Self-care is composed of self-care maintenance and self-care management.  
This process is further broken-down into the five stages included in the self-care of heart 
failure theoretical model by Riegel and Dickson (2008).   
Psychological 
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nursing 
process 
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cognitive 
variables 
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 Self-care Maintenance.  Self-care maintenance is defined by Riegel and Dickson 
(2008) as “behavior used to maintain physiologic stability-symptom monitoring and 
treatment adherence” (p. 192).  It is the first stage of the self-care of heart failure Model, 
to include treatment adherence and symptom monitoring.  Heart failure self-care 
maintenance activities include; medication adherence, low salt diet, exercises, engaging 
in illness preventive behaviors, and monitoring for signs/symptoms (Riegel et al., 2009). 
 Self-care Management.  The term is differentiated from self-monitoring by its 
characteristics of adaptation to chronic condition(s), effective communication, self-
efficacy, problem solving, and goal-setting (Wilde & Garvin, 2007).  According to Riegel 
& Dickson (2008), self-care management is the decision making process in response to 
symptoms.  It contains stages two to four of the self-care of heart failure Model.  Stage 
two is recognizing symptoms (e.g., weight gain and/or edema).  Stage three is symptom 
evaluation, during which the patient rationalizes why the symptom may have occurred 
(e.g., increase in fluid and/or sodium intake).  Stage four is treatment implementation, the 
process a patient makes to treat a symptom appropriately (e.g., extra diuretic dose).  Stage 
five is treatment evaluation, a process of analyzing if the intervention was successful and 
if not seeks help from a health professional.  Consistent execution of self-care 
maintenance and management may improve overall HF self-care.   
Quality of Life.  Quality of life is a broad theoretical concept with a multitude of 
definitions.  A definition of QOL is a sense of well-being, resulting from an individual’s 
satisfaction or dissatisfaction with what they consider important in their life (Bredow et 
al., 2009).  QOL is a patient’s subjective perception of a disease’s effect on activities of 
daily living (Chiaranai, 2007).  Heart failure diagnosis can diminish QOL due to several 
impairments caused or worsened by the disease (e.g., physical, socioeconomic, and 
psychologic) (Blinderman, Homel, Billings, Portenoy, & Tennstedt, 2008).  These factors 
are components of Padilla & Grant’s QOL Conceptual Model (Bredow et al., 2009).   
Health Diary.  Health diaries are categorized into two types (e.g., ledger and 
journal) (Eastwood et al., 2007).  Ledger diaries are formatted to record data as they 
occur.  Journal formats require entries even when there is no event, but provides more 
detailed information and useful in research (Eastwood et al., 2007).  Successful heart 
failure self-care can result in improved outcomes or quality of life.  Tracy (1999) found 
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that recording self-care behaviors in a diary format is associated with an enhanced quality 
of life. 
  
 
 
 
7 
 
 
 
Chapter Two: Review of Literature 
This chapter will present an overview of HF including epidemiology, 
pathophysiology, diagnosis, signs/symptoms, staging, and recommended therapy.  Patient 
education, nurse directed care, and self-care are major components of HF disease 
management.  Self-care is categorized into maintenance and management, with health 
diaries as a tool to record activities.  Improved quality of life is the goal of HF disease 
management.   
Heart Failure 
 Epidemiology.  According to the “Heart Disease and Stroke Statistics-2010 
Update” and data from the National Heart, Lung, and Blood Institute (NHLBI) 
Framingham Heart Study, HF incidence is approaching 10 per 1000 individuals of the 
population over the age of 65 years (AHA, 2010).  By the age of 40 years, the risk for 
developing HF is 1 in 5 for both men and women.  In 2006 the prevalence of HF in adults 
20 years and older was 5,800,000 individuals, with 3,100,00 males and 2,700,000 
females.  Diastolic HF is the most common cause HF in women, 40%-50% (Brashers, 
2006).  Individuals less than 65 years of age, 80% of men and 70% of women, will die 
from HF eight years after diagnosis (AHA, 2009).  Survival with heart failure beyond 
five years is less than 50% (Chriss, Sheposh, Carlson, & Riegel, 2004).  In 2006, in 
regard to race and gender, the prevalence of HF in Black females was the highest at 3.6% 
when compared to White males at 3.2%, Black males at 3.0%, White females at 2.1%, 
Mexican American females at 1.8%, and Mexican American males at 1.7% (AHA, 2010).   
Heart Failure hospitalization discharges continue to increase from 877,000 in 
1996 to 1,106,000 in 2006.  Exacerbation readmission within a 3-6 month period is 
estimated to be 25% to 50% of discharged patients (Chriss et al., 2004).  During 2006, 
HF any mention mortality (i.e., mentioned in death certificates) was 282,754 deaths. 
Heart failure was cited as the underlying cause in 60,337 of those deaths (AHA, 2010).   
Heidenreich et al. (2011) estimates that more than 40% of the US adult population (i.e. 
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116 million individuals) will have a form of cardiovascular disease, including HF, by the 
year 2030. 
Heart failure is a major contributor to the increasing costs of healthcare in the 
United States.  The estimated total cost of HF in the US was $37.2 billion in 2006 and 
increased to $39.2 billion in 2010 (AHA, 2010).  In the article “Forecasting the Future of 
Cardiovascular Disease”, the projected cost of Cardiovascular Disease (CVD) in the 
United States by 2030 is estimated to exceed $1 trillion (Heidenreich et al., 2011).  The 
United States’ direct medical cost of HF is projected to increase from $24.7 billion in 
2010 to $77.7 billion in 2030.  The indirect (i.e., loss of productivity) cost is projected to 
increase from $9.7 billion in 2010 to $17.4 billion in 2030 (Heidenreich et al., 2011).  HF 
is a growing societal and financial burden in the U.S.   
Pathophysiology.  Heart failure is characterized by two factors (a) a 
pathophysiological state in which inadequate cardiac output (CO) is unable to meet 
metabolic demands of tissues, or (b) elevated intracardiac pressures deliver adequate 
cardiac output but can precipitate systemic or vascular congestion (DiSalvo, 2005).  The 
most common cause of heart failure is left ventricular dysfunction.  Heart failure is 
categorized as either systolic or diastolic.   
Systolic Heart Failure.  Systolic heart failure is defined by a reduction in left 
ventricular contractility, unable to deliver adequate cardiac output, to adequately perfuse 
tissues with vital oxygen and metabolites (Brashers, 2006).  Myocardial infarction (MI) is 
the most common cause of reducing left ventricular contractility.  Systolic heart failure is 
characterized by an increase in ventricular preload, end volumetric pressure, and 
afterload, pressure required for ejection.  
Increased preload stretches the myocardium, weakens contractility, and decreases 
cardiac output. Reduced left ventricular contractility affects preload by decreasing 
volume of blood ejected during systole (i.e., stroke volume), increasing plasma volume 
left in the ventricle at the end of diastole (i.e., preload), and dilating the left ventricle 
(Brashers, 2006).    
According to Brashers (2006), increased afterload is a result of an increase in 
peripheral vascular resistance (PVR) commonly due to hypertension (HTN) and valvular 
diseases.  The process begins with (a) an increase in PVR causing resistance to left 
 
 
 
9 
ventricular emptying, (b) the workload is increased, (c) the myocardium remodels and 
becomes hypertrophied, (d) increase in oxygen demand increases, (e) collagen 
accumulates between myocytes (i.e., cardiac muscle cells), (f) integrity of the cardiac 
muscle is damaged, (g) cardiac contractility weakens, (h) the ventricle becomes dilated, 
and ultimately (i) Heart Failure.  The end result of increased afterload causes a decrease 
in cardiac output, therefore HF.   
The multiple effects of a decreased CO further complicates heart failure.  
Decreased renal perfusion activates the renin angiotensin aldosterone (RAA) system to 
increase PVR and plasma volume (Brashers, 2006).  This increases preload and afterload 
and further complicates heart failure.  The decrease in tissue perfusion activates 
baroreceptors that (a) activate the sympathetic nervous system to cause vasoconstriction 
and, (b) stimulation of the hypothalamus to produce antidiuretic hormone (ADH).  ADH 
increases water reabsorption from the kidneys, expands plasma volume, and ultimately 
worsens heart failure.  A decrease in CO activates neurohormonal and inflammatory 
systems resulting in apoptosis (e.g., cell death), myocardial remodeling, arrhythmias, and 
fluid retention.  Heart Failure consists of multiple harmful pathophysiologic events that 
worsen the already complicated disease process (Brashers, 2006). 
Diastolic Heart Failure.  Diastolic HF can occur in conjunction with systolic HF 
or independently (Brashers, 2006).  Diastolic HF is characterized by the presence of 
pulmonary congestion even with adequate CO and normal stroke volume.  Diastolic 
failure results from decreased compliance of the left ventricle and abnormal diastolic 
relaxation.  Decreased compliance of the left ventricle causes a usually normal preload 
volume to increase left ventricular end-diastolic pressure (LVEDP).  The pressure is 
reverted back to the pulmonary vasculature, therefore causing pulmonary congestion.  
Diastolic HF is caused by hypertension induced cardiomyopathy, valvular disease, and 
MI that results in remodeling.  Diabetes increases the risk for developing diastolic HF 
(Brashers, 2006). 
Diagnosis.  The most commonly used diagnostic test in evaluating patients for 
heart failure is the comprehensive 2-dimensional echocardiogram with doppler flow 
studies (AHA, 2009).  The test is used to determine the presence of abnormalities in the 
myocardium, heart valves, or pericardium.  AHA guidelines state that it is important for 
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the provider to assess if the left ventricle ejection fraction (LVEF) is preserved or 
reduced, normal/abnormal structure of left ventricle, and presence/absence of other 
structural abnormalities.  The echocardiogram is important in evaluating heart failure and 
may serve as a baseline for comparison, when there are changes in patient status.   
Brain natriuretic peptide (BNP) levels are increased in heart failure and found to 
decrease preload (Brashers, 2006).  Studies have shown that BNP levels are parallel to 
severity of HF (AHA, 2009).  BNP levels are elevated in those with reduced LVEF, LV 
hypertrophy, elevated LV filling pressure, acute MI, and ischemia.  Patients with 
symptomatic heart failure present with an elevated BNP level, therefore the lab test is 
useful in determining HF as the cause of dyspnea instead of other causes (e.g., chronic 
pulmonary disease, renal failure, hepatic failure).   
Signs and Symptoms.  Heart failure is characterized by a combination of signs 
symptoms that may differ with each patient.   HF symptoms include exertional dyspnea, 
orthopnea, paroxysmal nocturnal dyspnea, elevated jugular venous pressure, pulmonary 
rales, third heart sound (i.e., S3), and peripheral edema (DiSalvo, 2005).  Other chronic 
conditions may present similarly to HF, therefore diagnosis may be differentiated with 
BNP levels and an echocardiogram.  Medications and lifestyle changes (e.g., self-care) 
are geared to decrease symptom effects and increase functioning in activities of daily 
living (ADL).  The main goal of treatment is improving QOL. 
The New York Heart Association (NYHA) Heart Failure Symptom Classification 
System is subjective, but widely accepted by healthcare providers (AHA, 2009).  The 
purpose of the classification is to assess severity of functional limitations and correlates 
with prognosis.  The four classification levels are (a) NYHA class I, no symptom 
limitation and ordinary physical activity; (b) NYHA class II, ordinary physical activity 
limited by dyspnea; (c) NYHA class III, moderate exercise limited by dyspnea; and (d) 
NYHA class IV, dyspnea at rest or with little exertion.  
According to the AHA (2009), patients with LV dysfunction usually present with 
HF in three ways.  First, decreased exercise tolerance.  Usually patients seek medical 
attention complaining of dyspnea and/or fatigue with ADL.  Patients and/or healthcare 
providers may attribute these symptoms with aging, other physiological abnormalities 
(e.g., de-conditioning from inactivity), or other medical disorders (e.g., pulmonary 
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disease).  It is important to distinguish HF or another condition as the cause of symptoms.  
Second, patients may present with fluid retention (e.g., swelling of lower extremities 
and/or abdomen).  Third, patients may exhibit cardiac enlargement or dysfunction after 
being evaluated for HTN, abnormal chest x-ray, arrhythmia, or acute MI (AHA, 2009).      
Weight gain is a sign of decompensating HF (Chaudhry, Wang, Concato, Gill, & 
Krumholz, 2007).  The goal of the authors’ study was to identify weight gain as a trend 
that preceded hospitalization and as a risk factor for imminent hospitalization.  The 
research was an 18 months case-control study that used data from an electronic home 
monitoring system to transmit weight to a database monitored by nurses.  The case study 
group included 134 patients with HF hospitalization and the control group included 134 
patients without hospitalization.  The patients were instructed to weigh themselves daily.  
A gain of at least five pounds, in three days, was automatically reported by fax to the 
patient’s physician.  The physicians then decided on appropriate intervention(s) or change 
in therapy.  In the case group, the study found that a trend in weight gain started about a 
week before hospital admission.  The control group retained a stable weight.  Daily 
weight trends within 30 days pre-hospitalization were statistically significant (p <0.001).  
Adjusted for comorbid conditions, the study results for heart failure hospitalizations were 
(a) weight gain greater than two and up to five pounds were associated with an adjusted 
matched OR of 2.77 (95% CI [1.13-6.80]), (b) weight gain greater than five and up to ten 
pounds with adjusted matched OR = 4.46, 95% CI [1.45-13.75], and (c) weight gain 
greater than ten pounds with adjusted matched OR = 7.65, 95% CI [2.22-26.39].  Higher 
amounts of weight gain were strongly associated with increasing the risk for 
hospitalization.  In summary, weight gain can increase the risk for hospitalization and 
evident at least one week prior.  Healthcare providers’ awareness of a patient’s change in 
status (e.g., weight gain) indicates an opportunity for clinicians to intervene (e.g., 
increase diuretic dosage).  Early detection and intervention may avoid exacerbation and 
hospitalization (Chaudhry et al., 2007).  
Staging and Recommended Therapy.  The American College of Cardiology 
Foundation (ACCF)/American Heart Association (AHA) “Guidelines for Diagnosis and 
Management of Heart Failure in Adults” divided the disease process into four stages of 
development (see Figure 3).  The guidelines serve to define practice and provide quality 
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care.  However, each patient is unique and there may be situations that require deviation 
from the guidelines.  The physician and patient must collaborate on an appropriate 
treatment plan.  Stages A and B include patients at high risk for developing HF.  Stages C 
and D includes the patients already diagnosed with HF. 
 
 
 
Figure 3.  Heart Failure staging and recommended therapy.  Adapted from “2009 
Focused Update Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and 
Management of Heart Failure in Adults”, by AHA, 2009, Circulation, 119, p. 398.  
Copyright 2009 by the American Heart Association. 
 
 
Stage A.  Stage A includes individuals at high risk for HF, but asymptomatic 
and without structural heart disease (AHA, 2009).  The risk factors are atherosclerotic 
disease, diabetes, obesity, metabolic syndrome, cardiotoxins (e.g., cocaine), and family 
history of cardiomyopathy.  Hypertension remains to be the most common risk factor for 
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heart failure.  In fact, 75% of patients diagnosed with heart failure had a history of 
hypertension.  The risk is double for people with an average blood pressure (BP) greater 
than 160/90 mmHg compared to those with a BP less than 140/90 mmHg. The AHA 
recommended management strategies include hypertension treatment, encouraging 
smoking cessation, treating lipid disorders, exercising regularly, controlling metabolic 
syndrome, discouraging alcohol consumption, and deterring from illicit drug use.  
Medical therapy should include angiotensin converting enzyme inhibitor (ACEI) or 
angiotensin II receptor blocker (ARB) (AHA, 2009). 
Stage B.  Stage B is characterized by the presence of structural heart disease, but 
absent of HF symptoms (AHA, 2009).  These patients include those with a medical 
history of previous MI, left ventricular remodeling with a low ejection fraction, and 
asymptomatic valve disease.  Recommended management is similar to Stage A.  Medical 
therapy includes ACEI or ARB plus a beta-blocker. According to the AHA, implantable 
defibrillators are recommended for selected patients at high risk for deadly arrhythmias.    
Stage C.  Stage C includes patients with known structural heart disease and 
symptoms of heart failure (e.g., fatigue, activity intolerance, and shortness of breath) 
(AHA, 2009).   Therapy goals include a low sodium diet in addition to Stage A and B 
regimen.  Medical therapy includes beta-blockers, diuretics, ACEI and/or ARB.  Selected 
patients will also be prescribed aldosterone antagonist (e.g., spironolactone), Digoxin, 
Hydralazine, and/or Nitrates.  Implantable cardiac defibrillators (ICD) are recommended 
for those at high risk for arrhythmias.   
For some patients in stage C, a combination of an ICD and Cardiac 
resynchronization therapy (CRT) device is recommended.  A CRT device electrically 
stimulates the contraction of the ventricles in a synchronized manner, via biventricular 
pacemaker.  According to the AHA (2009) the CRT has shown to enhance ventricular 
contraction, reduce mitral regurgitation, and improve hemodynamics without increasing 
oxygen demand.  CRT devices reduce heart failure admissions by 32% and mortality by 
25%.  The device also decreases hospital readmissions for patients with persistent 
symptomatic HF.  The AHA states that there is strong evidence that CRT improves 
symptoms, exercise capacity, QOL, LVEF, and survival.         
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Stage D.  Stage D is defined as heart failure refractory to maximum medical 
treatment and require specialized interventions (AHA, 2009).  Patients are symptomatic 
even at rest, have profound fatigue, unable to perform ADL, and cannot be safely 
discharged from the hospital.  These patients are noted for frequent and/or prolonged 
hospitalizations.  Therapy goals include measures in Stage A, B, and C.  Decisions in 
regard to end-life care (i.e., hospice) need to be discussed with the patient and their 
family.  Extraordinary treatment options include heart transplant, chronic inotropes, 
permanent mechanical support, and experimental surgery/drugs (AHA, 2009).  
A controversial treatment is intermittent intravenous positive inotropic therapy 
(e.g., dobutamine and milrinone) administered in outpatient clinical settings (e.g., heart 
failure clinic) or at home (e.g., home health care).  Positive inotropes act to increase 
contractility and increase CO (Petersen & Felker, 2008).  The harmful effects include 
increase in oxygen demand and arrhythmias, therefore not indicated for short or long 
term therapy.  According to the AHA (2009), long-term oral inotropic therapy has shown 
to increase mortality significantly and does not improve clinical status or symptoms.  The 
AHA states that the only benefit associated with intermittent inotropic treatment in the 
outpatient setting results from the increased surveillance by healthcare providers.  The 
AFFC/AHA does not recommend intermittent infusion of positive inotropic agent for 
long-term treatment of HF, even in advanced stages.  However, continuous positive 
inotropic agents (e.g., dobutamine, dopamine, and milrinone) are sometimes administered 
as palliative treatment to allow patients to die in comfort (AHA, 2009).  
Disease Management 
The Cochrane Review “Clinical Service Organisation for Heart Failure 
(Review)” states that traditionally, HF management emphasized only acute care.  
However, HF management is now evolving its focus towards more proactive and 
preventive disease management models (Taylor et al., 2009).  The three types of HF 
disease management models include (a) multidisciplinary, (b) case management, and (c) 
clinic.  Multidisciplinary models offer a holistic approach in managing HF.  The 
multidisciplinary team involves different professions (e.g., medical, psychosocial, 
behavioral, and financial) working in collaboration.  Case management models are 
characterized by intense monitoring of patients post-discharge.  Case management is 
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conducted by a nurse and involves home visits and/or telephone calls.  The clinic models 
include outpatient clinics run by cardiologists or nurses guided by protocol.  Only one 
multidisciplinary intervention study was included in the review.  The multidisciplinary 
models resulted in preventing hospital readmissions in the short term.  Only two clinic 
interventions studies were included in the review, but they lacked statistical power and no 
evidence of any benefit. The review found that case management models reduced all 
cause mortality, from the analysis of better quality studies, OR 0.68, 95% CI [0.46-0.98, 
p = .04.  Some case management interventions supplied patients with diaries and charts 
for recording self-care maintenance (Taylor et al., 2009).     
Participation in HF disease management programs have shown to improve 
functional status, improve quality of life, and reduce hospital admissions due to 
exacerbations (Rockwell & Riegel, 2001).  Post-discharge support has shown to reduce 
readmission rates, improve health outcomes, and enhance QOL.  Studies show that a one-
hour session of patient education from a nurse educator improved clinical outcomes, 
reduced costs, and increased treatment adherence (Rockwell & Riegel, 2001).  The 
ACCF/AHA management guidelines state that patient education and close supervision 
improves treatment adherence (AHA, 2009).  Performing self-care leads to early 
detection of symptoms, allowing the patients and/or healthcare providers to initiate 
treatments that prevent exacerbations.  According to the guidelines, nurses with special 
training in HF are sufficient in supervising patients’ self-care and the presence of a 
physician is not required (AHA, 2009).     
Patient Education.  Nurses are the key providers of patient education 
(Washburn & Hornberger, 2008).  Heart Failure self-care education has proven to 
decrease hospital readmission rates, lower risk for death, and decrease costs of care 
(AHA, 2009).  Patient education topics include symptoms of HF, weight management, 
dietary recommendations, medications, and exercise (Washburn & Hornberger, 2008).  
Symptom recognition is an important step in the HF self-care process.  Weight gain 
usually precedes hospitalization, recognizing these trends can prevent exacerbations 
through a change in treatment (Chaudhry et al., 2007).  A sodium-restricted diet is 
standard for HF patients.  Patients should be made cautious of salt substitutes because 
they are potassium based and can affect medications.  Reading food labels and avoiding 
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high sodium foods (e.g., canned and frozen foods) should be recommended.  Patients 
should be taught medication action, dosage, frequency, and side effects.  They should 
also be encouraged to bring a list of all their medications to physician visits.  Patients 
should be warned against non-steroidal anti-inflammatory drugs (NSAID) because they 
interfere with medical therapy.  Exercise should be encouraged because it has proven to 
improve symptoms, QOL, balance, and functional capacity.     
The ACCF/AHA guidelines state that written instructions must be given to 
patients at discharge and include: activity level, diet, discharge medications, follow-up 
appointment, weight monitoring, and symptom interventions (AHA, 2009). Health care 
providers cannot assume that written patient education alone promotes self-care.  
According to the study “Factors Influencing Knowledge of and Adherence to Self-care 
Among Patients with Heart Failure” 37% of 113 patients reported they knew “little or 
nothing” after receiving written and verbal heart failure education (Ni et al., 1999).  In 
order to adequately teach self-care activities, nurses should take time to understand each 
patient’s ability to learn and perform necessary behaviors (Rockwell & Riegel, 2001).  
Importantly, patient education should be individualized due to the variability of each 
patient’s self-care abilities. 
Nurse Directed Care.  A study by Kutzleb & Reiner (2006) found that nurse 
directed and focused interventions significantly improves QOL.  The authors carried out 
a quantitative quasi-experimental design comparing nurse-directed care (NC) and routine 
care medical management (RC).  A cardiologist and cardiac nurse specialist managed the 
NC group.  A cardiologist and cardiology fellows managed the RC group.  The clinical 
nurse specialist performed physical examination, initiated prescribed medical therapy, 
and provided an individualized educational plan.  Patients in the NC group were provided 
a calendar to document daily weight.  The RC group was provided counseling on topics 
of smoking cessation, medications, and nutrition.  NC group interventions were 
monitored by telephone follow-up and the RC group was not.  The results show that 80% 
of the RC group reported never being placed on or did not follow the recommended diet.  
The RC group also had lower adherence to medications.  Eighty-four percent of the NC 
group actively engaged in exercise, compared to 40% for the RC group.  For the NC 
group there was an overall and significant improvement in QOL, F(5, 63) =13.569, p = 
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.0000.  The NC group described that their ability to manage diet and medications was the 
most positive change in their quality of life (Kutzleb & Reiner).   
The study concluded that nurse directed focused interventions reinforced 
diligent self-care maintenance, improved QOL, and treatment adherence (Kutzleb & 
Reiner, 2006).  The nurse directed care interventions improved the QOL of patients with 
HF.  This was the basis for including individualized education, weekly follow-up for a 
period of four weeks, and a health diary into this study.  Nurse directed care provides 
added benefits when added to the traditional medical management.   
Self-Care.  According to ACCF/AHA guidelines, close observation and follow-
up is the most effective and unfortunately least used measure in HF management (AHA, 
2009).  The treatment of HF is only effective with active self-care participation and 
treatment adherence, therefore health care providers should make every effort to 
encourage and engage them.  Patients with heart failure are responsible for the majority 
of their care including medication adherence, daily weight monitoring, low 
sodium/cholesterol diet, limiting fluid intake, and exercising as tolerated.  Non-
compliance with prescribed medications and sodium/fluid restriction is a common factor 
in precipitating hospitalization.  Increases in body weight and minor symptoms occur 
several days prior to severe clinical episodes that require hospitalization (Chaudhry et al., 
2007).  
A non-experimental correlational study by Rockwell & Riegel (2001) analyzed 
predictors of self-care in persons with heart failure.  The authors hypothesized that 
severity of symptoms, comorbidity, social support, education level, age, socioeconomic 
level, and gender are predictors of heart failure self-care.  The study found only two of 
the variables to have strong significance in predicting self-care, educational level and 
severity of symptoms.  Patients with higher education were associated with treatment 
compliance and healthy behaviors.  However, they recognized that a person with lower 
education level can learn self-care, but needs more time to be taught the process.  Patients 
with severe symptoms were found to have high self-care scores.  Having experienced 
frequent exacerbations, these patients became experts in recognizing severe symptoms 
and actively participated in self-care.  Personal experience with exacerbations contributes 
to symptom recognition and motivates self-care.  On the contrary, individuals with mild 
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HF may have difficulty in recognizing symptoms and understanding the purpose for self-
care (Rockwell & Riegel, 2001).  
According to Rockwell and Riegel (2001), self-care behaviors require patients to 
make reasonable, knowledgeable, and thoughtful judgments about symptoms and 
response to treatment. The authors describe self-care as an active and cognitive process, 
that patients engage in for the purpose of maintaining health or managing illness.  Poor 
self-care is associated with poor outcomes in HF.  Those who do not actively participate 
in self-care are frequently readmitted to the hospital (Chriss et al., 2004).   
Self-care Maintenance.  Many signs of heart failure decompensation can be 
anticipated with self-care maintenance.  Self-care maintenance involves the symptom 
monitoring and treatment adherence stages of the self-care of heart failure model (Riegel 
& Dickson, 2008).  Monitoring involves measuring, recording, and observing for 
symptoms.  The heart failure disease process requires patients to maintain a balance 
between physiologic compensation and decompensation.  Subtle symptom awareness is 
very important and is achieved through diligent recording of symptoms (e.g., weight gain, 
edema, shortness of breath, fatigue).  Self-care maintenance is linked to improving body 
awareness, communication with healthcare providers, and sense of empowerment in 
controlling disease process (Eastwood et al., 2007).    
There are multiple factors that influence self-care maintenance.  Patients with 
comorbid conditions show to have a lower level of self-care performance (Chiaranai, 
2007).  The author observed that a higher level of education and strong social support 
positively influenced self-care behavior.  Chris et al. (2004) found that higher education 
does not predict level of self-care maintenance.  The author concluded that older male 
patients had better self-care maintenance and attributed it to their satisfaction with 
independent problem solving of health issues (Chris et al., 2004). 
Adequate self-care maintenance is very important in the management of HF.  
Benefits include the improvement of body awareness, sense of empowerment, and 
communication with providers and caregivers.  Self-care maintenance activities of 
patients with HF include medication adherence, daily weight monitoring, dietary 
restrictions, limiting fluid intake, and exercise.  With some similarity to overall self-care, 
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factors that may affect self-care maintenance include comorbidities, educational level, 
age, gender, and social support.  Health diaries are tools for maintaining self-care. 
Health Diary.  A majority of the elderly population has been diagnosed with a 
chronic disease and may experience symptoms on a daily basis.  Historically, prospective 
diaries have been used in research data collection since the 1950’s and continue to be 
used in nursing studies (Aroian & Vander Wal, 2007).  Perceived symptom experiences 
is the most important factor in determining whether elderly individuals will partake in 
self-care or seek medical care.  The possible drawbacks of daily diaries they may be 
viewed as burdensome, timely, and chronic illness symptoms may be overlooked due to 
acclimation.  There is very little information in the literature on the number of diary days 
necessary to produce sufficient research data.  Aroian & Vander Wal (2007) performed a 
methodological study investigating the utilization of a seven days prospective symptoms 
diary and retrospective symptom report (RSR) in a community-dwelling elderly 
population.  The research questions were (a) whether a 7 day daily symptom diary 
yielded any new information from the first diary day, (b) degree of comparability of 
experiences with prospective daily symptom diary with RSR, (c) which of the two 
methods (e.g., daily diary or retrospective reports) produced data more consistent with 
reports of functional health status.  The research findings concluded that (a) the total 
number of symptoms reported on each day of the daily diary declined, F(6, 214) = 13.51, 
p< .0001 (b) 82.7% of symptoms reported on the first diary day was also reported on 
subsequent diary day, (b) the majority of symptoms were endorsed more frequently with 
RSR.  The study results concluded that RSR had a strong significant correlation to 
physical, r = -0.51, p < .0001 and mental, r = -0.40, p < .0001, health summary scores of 
functional health status. Daily diary use had a lower significant correlation to physical, r 
= - 0.43, p < .0001 and mental, r = - 0.31, p < .001 health summary scores of the 
functional health status.  However, the difference between the RSR and daily diary was 
not statistically significant, physical, t(304) = 1.62, p = ns and mental, t(304) = 1.90, p = 
ns.  According to the authors, a major limitation of the study is the daily diary may have 
played a major role in causing the participants to be more sensitive to and have better 
recall of symptom experiences to complete the RSR.  Other study limitations include the 
failure of acquiring RSR before and after daily diary use.  Aroian & Vander Wal (2007) 
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suggest that daily diaries use may be appropriate for recording time-series data, for 
example monitoring the progression of symptoms over time.   
Eastwood et al. (2007) performed a retrospective descriptive study on the effects 
of using a heart failure health diary on clinical and hospital outcomes.  Prior to Eastwood 
et al.’s 2007 research, only one study focused on HF diary use and found users to be on 
more recommended medications, likely to attend education classes (e.g., HF clinics or 
primary care visits), experience less symptoms, and associated with lower mortality rates.  
The non-randomized sample included participants of a HF clinic whom were given the 
option to use the Heart Health Diary, developed by the researchers.  The sample 
characteristics were patients classified as NYHA II-IV Class and had difficulty adhering 
to treatment.  The mean age of diary users were 65 years (+ 11.9 years), 50 men, and 42 
women.  The mean age of diary non-users were 56.7 (15.4) years, 32 men, and 22 
women.  NYHA classification and BNP levels were not significantly different between 
the groups. Diary users contacted healthcare providers 35% more than non-users.  Diary 
user attended the clinic 47% more than non-users.  Six months after the intervention, 
ejection fraction improved in diary users, n = 50, from 27% (11.2%) to 29.3% (14.2%).  
There was no change in the LVEF for diary non-users.  NYHA and BNP levels improved 
significantly for both groups, the authors recognized this as may be a result from their HF 
clinic attendance.  Hospital admission, showed no significant difference between groups. 
Length of stay was decreased more significantly in diary users from 9.8 (9.5) to 4.1 (6.3) 
days.  Eastwood et al. (2007) found diary users to have better outcomes than non-users.  
A study “Improving Heart Failure Symptom Recognition: A Diary Analysis” 
aimed to determine patient adherence to daily weight monitoring, identify reasons for 
non-adherence, determine the prevalence of > 3lbs in 1 day, and ascertain the frequency 
participants sought medical advice for weight gain of > 3lbs (White, Howie-Esquivel, & 
Caldwell, 2010).  The study provided patients with a daily diary.  The diary was for 
weight and symptom monitoring.  The study was a randomized 2-group experimental 
design, intervention group (n=20) and care as usual group (n=16).  Patient education and 
counseling was provided to all participants.  The intervention group was given a three 
month daily diary to record daily weight, symptoms, unplanned hospital visits, and 
physician contacts.  Symptoms to be recorded on the diary included swollen ankles, 
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swollen hands, weight gain, shortness of breath, and reduced exercise capacity.  Sixteen 
of the total 20 patients from the intervention group completed their diaries.  The study 
resulted in 79.4% of participants adhering to daily weight monitoring.  Reasons for non-
adherence included vacation, holiday meals, and forgetfulness.  A total of 75% had a 
weight gain of > 3lbs in one day.  Only one participant contacted their physician for a 
weight gain > 3lbs.  Although the study was of a small sample size, it concluded that 
adherence to daily weight monitoring may be achieved when incorporated with patient 
education and utilization of diaries (White et al., 2010).  
There were few studies in the literature review that incorporated health diaries in 
the intervention or the number of diary days necessary to produce sufficient research 
data.  Diary use was found to have many benefits including improving adherence, 
monitoring trends, decreasing length of hospital stay, and improving ejection fraction.  
Factors affecting the use of diaries included age and educational level, which similarly 
affects self-care.  The drawbacks of diaries are that they may be viewed as timely or 
burdensome.  Reasons for non-adherence include holidays, vacations, and forgetfulness.  
These are similar reasons why even healthy individuals derail from their health plan. 
Self-Care Management.  Self-care management encompasses stages two to five 
of the self-care of heart failure model: (1) symptom monitoring and treatment adherence, 
(2) symptom recognition, (3) symptom evaluation, (4) treatment implementation, and (5) 
treatment evaluation (Riegel & Dickson, 2008).  Preventing decompensation by 
responding to symptoms is the goal of self-management (Chriss et al., 2004).   
Symptom recognition is important for patients because early signs can be subtle, 
but will progress to an exacerbation if left untreated.  An important factor in HF self-care 
is properly recognizing symptoms, initiating an appropriate course of action, and 
evaluating its effect on symptom relief (Chriss et al., 2004).  An understanding of the 
symptoms, treatments, and overall heart failure self-care will positively affect the 
patients’ symptom awareness and response (Chiaranai, 2007).   
Chiaranai (2007) found that younger women responded quickly to symptoms 
and performed appropriate self-care management than older women.  This may be 
attributed to difference in age, memory, motor response times, and problem solving 
skills.  Individuals with lower income were shown to also respond more quickly than 
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those with a higher income.  The author suggests that this may be to avoid expenses and 
economic burden (e.g., hospital costs).  Adequate level of self-management may result in 
fewer symptoms, better functional capacity, and improved quality of life (Chiaranai, 
2007).  
A study by Gallagher, Donoghue, Chenoweth, & Stein-Parbury (2008) identified 
six predictors of self-management in chronic illness as (a) the primary diagnosis, (b) 
length of time diagnosed, (c) age, (d) sense of coherence (SOC), (e) self-perceived health, 
and (f) self-efficacy.  Sense of coherence is defined as “a pervasive feeling of confidence 
that life and life’s demands are comprehensible, meaningful, and manageable” (Gallagher 
et al., 2008, p. 374).  Primary chronic illness diagnosis included in the study included HF, 
chronic respiratory disease, Parkinson’s, and Schizophrenia.  The Partners in Health 
Scale instrument was used to measure self-management.  The tool used a Likert scale to 
rate self-management by primary diagnosis from very good (0) to very poor (88).  
Schizophrenia associated with very poor self-care, Parkinson’s second, and HF third.  
Mean self-management scores for patients with HF was 19.67 (13.68), p <  .000, ranking 
third after Schizophrenia and Parkinson’s disease (Gallagher et al., 2008).  Correlates of 
poor self-management include (a) elderly patients with low perceived health, (b) recent 
diagnosis, (c) low SOC scores, and (d) worse self-efficacy scores. The study concluded 
that the type of primary diagnosis was a strong predictor of self-management.  However, 
longer length of illness improved self-management (Gallagher et al., 2008).  
Self-care management differs from self-care maintenance in that it is the process 
one recognizes and analyzes symptoms, implements a plan of action, and evaluates the 
effectiveness.  Factors affecting management includes length of diagnosis, age, gender, 
and socioeconomic status.  The psychological factors that may affect HF self-care 
management include self-confidence, self-perceived health, and self-efficacy.  The 
adequacy of self-care management activities is of great influence in determining a 
positive or negative outcome.  The ultimate goal in HF management is improving the 
QOL of patients. 
Measuring Self-Care. The Self Care of Heart Failure Index (SCHFI) was used in 
this study to measure self-care adequacy.  The SCHFI is based on Riegel & Dickson’s 
(2008) theoretical model of HF self-care.   
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Reliability.  According to Riegel et al. (2009), a prospective study of community-
dwelling patients, n = 154 with HF was used to determine the SCHFI reliability.  The 
subscales of the SCHFI have a coefficient alpha for self-care maintenance, n = 154, α = 
.553, 95% CI [.439, .542]; self-care management, n = 73, α = .597, 95% CI [.434, .590]; 
and self-care confidence, n = 154, α = .828, 95% CI [.781, .836].  The developers 
expected a low internal consistency of the self-care maintenance subscale because it 
reflects a wide variety of behaviors and lifestyle changes that may have little association 
with each other (e.g., exercise and medication adherence).  There were significant 
differences in each individuals responses as depicted in the variance of mean values of 
the maintenance subscale, F = 122.45, p < .001; management subscale, F = 3.71, p < 
.001; and confidence subscale, F = 20.58, p = .001.  The individual self-care 
maintenance, self-care management, and self-care confidence scales were not highly 
intercorrelated, with no r = > .43, indicating that it measures the subscales as individual 
constructs and therefore should be scored separately (Riegel et al., 2009).   
According to Riegel et al. (2009), there was no learning effect, with minimal 
changes in scores over time.  The difference in scores was not statistically different.  The 
learning effect was assessed through comparison of baseline values to patient responses 
one and two months later.  The mean score at baseline was, 70.49 (14.32), n = 130; after 
one month, 68.40 (16.61), r = 0.443, p = < 0.01, n = 130; and after two months, 69.66 
(15.06), r = 0.470, p = <0.01, n = 110.  The SCHFI scores when compared with the 
Social Desirability Scale score did not result in any significant correlation, with self-care 
confidence having the highest, n = 33, r = .32, p = .07 (Riegel et al., 2009). 
Validity.  According to Riegel et al. (2009), the validity of the SCHFI was 
assessed qualitatively and quantitatively.  Validity was assessed with two separate 
studies, through which researchers compared qualitative with quantitative data (i.e., 
SCHFI).  The first study, of which self-care adequacy was derived from nurse-patient 
dialogue, resulted in low congruence between qualitative and quantitative data.  The 
second study consisting of a semi-structured interview guide classified participants as 
poor, good, or expert in HF self-care.  This study resulted in a parallel increase between 
SCHFI scores and expertise: self-care maintenance score mean compared to poor, 70 
(16.9), good 80 (12.2), and expert, 85 (5.0) (Riegel et al., 2009).  
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The European Heart Failure Self-Care Behavior scale is a 5-point Likert scale 
measuring self-care maintenance and was used in comparison to the SCHFI to test 
concurrent validity (Riegel et al., 2009).  The two questionnaires resulted in a moderate 
correlation, r = .65, p < .001.  Riegel et al. (2009) found the overall model fit of the 
SCHFI as adequate, x2 = 356.92.   
Construct validity testing used confirmatory factor analysis to determine whether 
the SCHFI appropriately measured each subscale’s constructs (i.e., maintenance, 
management, and confidence).  From a sample of 154 patients, the study concluded that 
maintenance correlated with confidence, which itself correlated with management (Riegel 
et al., 2009). 
Scoring.  It was recommended by Riegel et al. (2009) to analyze each section 
separately.  The self-care maintenance subscale (i.e., Section A) of the SCHFI was used, 
which is the study’s focus.  It is a Likert scale format with the frequency of self-care 
maintenance activities ranging from: 1 (i.e., never or rarely), 2 (i.e., sometimes), 3 (i.e., 
frequently), and 4 (i.e., always or daily). The self-care maintenance scale score ranges 
from 10-40, this is then standardized to a range of 0 to 100.  The standardized score is 
calculated by the formula (sum of Section A items – 10)3.333.  A score of greater than 
70, demonstrates self-care adequacy.  Question 5 (i.e., forget to take one of your 
medicines), is a reverse scored item which may make the investigator’s calculation or 
patients’ ability to respond appropriately complicated. 
Summary.  The medical treatment of HF is only effective if the patients are 
actively partaking in their own self-care.  Benefits of adequate self-care include early 
detection that allows the patients and/or providers to initiate treatments in order to avoid 
exacerbations.  Studies have shown that worsening symptoms occur days before they 
become severe enough to require hospitalization.  Factors affecting self-care adequacy 
include education and symptom severity.  Higher education was associated with 
compliance and healthier behaviors.  More severe symptoms were easier to recognize 
versus milder symptoms, and therefore these patients were found to have higher self-care 
compliance.  Utilizing tools that measure self-care adequacy, such as the SCHFI, may be 
beneficial for patients and providers in monitoring health status.  As providers, our role is 
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in encouraging and engaging our patients to be active in their self-care.  Even with an 
adequate support system, it really comes down to the patients themselves. 
Quality of Life 
Several factors affecting the QOL for patients with HF include health status (i.e., 
symptoms related to illness), functional capacity, demographic factors (e.g., age), and 
psychological state (Blinderman et al., 2008).  These factors impact an individual’s 
ability to function in everyday life and adapt to illness.   
Heart failure symptoms (e.g., dyspnea and fatigue) can limit ADL functioning 
(Rector, Anand, & Cohn, 2006).  Blinderman et al. (2008) studied the effect of HF 
symptom distress on QOL.  There was a very strong correlation between symptom 
distress and QOL, r = -0.74, p < 0.001.  The four most prevalent symptoms were lacking 
energy, dry mouth, shortness of breath, and feeling drowsy.  Additional factors that 
impaired QOL include comorbidities r = -0.32, p = 0.002; female gender, r = -0.22, p = 
0.03; and functional capacity as measured by Sickness Impact Profile (SIP).  
Psychological factors, r = -0.55, p < 0.001, compared to physical dysfunction, r =-0.41, p 
< 0.001, showed greater association with QOL.  Psychological well-being had a positive 
impact on quality of life, r = 0.68, p <0.001.  In summary, impaired function capacity 
adversely effects QOL, but psychological factors is shown to be a strong influence as 
well (Blinderman et al., 2008).     
Chiaranai (2007) studied the relationship between self-care and QOL.  The study 
was based on the self-care of heart failure model developed by Riegel et al. (2004).  
Chiaranai (2007) performed a non-experimental study measuring the relationships 
between self-care strategies and QOL.  Lower NYHA classification, fewer comorbid 
diseases, fewer symptoms and younger age were found to correlate with an enhanced 
quality of life.  The study resulted in identifying self-care management as the best 
predictor for disease-specific QOL.  The author found that QOL was not influenced by 
self-care maintenance, although QOL was associated with overall self-care performance 
(Chiaranai, 2007).        
Rector et al. (2006) studied the relationship between clinical assessments and 
patients’ perceptions on QOL.  The authors performed secondary analysis of data from a 
previous multicenter, randomized, placebo-controlled, and double blind study of 
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Valsartan (i.e., Valsartan Heart Failure Trial).  Higher NYHA classification associated 
with worsening MLHF QOL scores.  Fatigue was found to vary MLHF scores by 38% 
and NYHFA classification by only 19%.  Patients’ age >65 years varied the scores by 
4.5%.  Patients’ jugular vein distention (JVD), EF, and BNP values were not shown to 
affect QOL scores.  Common symptoms (e.g., peripheral edema, pulmonary rales, and 
JVD) accounted for 40% of variation in MLHF scores, identifying their substantial effect 
on QOL (Rector et al., 2006).     
The differences between age and gender caused minimal variation in MLHF 
scores (Rector et al., 2006).  Factors affecting age related differences are employment, 
financial status, physical activities, and mental state.  The emotional effect on QOL 
negatively affected women. Women reported more dyspnea and fatigue, therefore scored 
lower QOL than men (Rector et al., 2006). 
Measuring QOL.  The Minnesota Living with Heart Failure Questionnaire was 
used to measure QOL.  It is intended to measure the effects of HF and treatments on a 
patient’s quality of life (Rector, 2005).  Developed in 1984, the MHLFQ is the most 
commonly used instrument in HF QOL research.   
Reliability.  Since 1984, multiple studies have tested the reliability of the 
MLHFQ.  The psychometric properties of the MLHFQ consistently demonstrates a 
satisfactory level of reliability, > α = .80, when compared with other QOL measurement 
tools (i.e., RAND-36 Short Form, Multidimensional Fatigue Inventory, and Hospital 
Anxiety and Depression Scale) (Middel et al., 2001).  The MLHFQ’s ability to detect a 
change over time within one group was demonstrated to have a moderate effect size d = 
0.65, r = 0.67.  The most recent study using the MLHFQ was the Valsartan Heart Failure 
Trial which resulted in a high internal consistency, α = 0.86 (Rector, 2005).  High 
reliability was also induced in other studies: “Evaluation by Patients with Heart Failure of 
the Effects of Enalapril Compared with Hydralazine Plus Isosorbide Dinitrate on Quality 
of Life”, n = 152, r = 0.87; “Assessment of Quality of Life as Observed from the 
Baseline Data of the Studies of Left Ventricular Dysfunction Trial Quality of Life 
Substudy” for the NYHA Class I group, n = 135, α = .95 and the NYHA Class II group, 
n = 123, α = .94; “Discriminant Properties of Commonly Used Quality of Life Measures 
in Heart Failure”, of NYHA Class I - IV patients, n = 211, α =  .95; and “Psychosocial 
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Variables and Hospitalizations in Persons with Chronic Heart Failure” of NYHA Class I - 
IV patients, n = 62, α = .92.  The MLHFQ consistently shows a high reliability, α > .8 
(Rector, 2005).   
Validity.  MLHFQ scores significantly varies between NYHA Class groups in 
multiple studies, p < .0001 (Rector, 2005).  A psychometric study of the MLHFQ 
demonstrated a discriminative ability of, z = -3.8, p = .0003, d = 1.25, between the 
NYHA Class mean overall scores for the NYHA Class I, 11.7 (16.5), n = 15, and NYHA 
Class II/III, 33.9 (18.1), n = 38, (Middel et al., 2001).  Rector (2005) verified the 
MLHFQ’s correlation with other HF measurement tools: Chronic Heart Failure score, r = 
.81; Functional Status Scale r = .75; Dyspnea scale, r = .52; Six-minute Walk Test r = 
.39; and Ejection Fraction, r = .03 (Rector, 2005).  The MLHFQ’s test-retest ability was 
tested over a three month period showing a satisfactory correlation between the scores, 
but the change was not significant, r = .73, z = -1.28, p = .20 (Middel et al., 2001). The 
mean pretest score was, 29.79 (18.65) and the three months mean posttest score, 26 
(20.34) (Middel et al., 2001). 
Scoring.  The MLHFQ score range from 0 to 105, the higher the score the lower 
the QOL.  According to Rector (2005) there is not a definitive cutoff value to determine 
improvement or deterioration in QOL when scoring the MLHFQ.  The author states that 
the total score represents the best measure of how HF has affected a patient’s QOL, even 
if all of their individual question responses are not consistent.   
Multiple randomized controlled studies have shown the MLHFQ’s ability to 
detect differences between interventions (Rector, 2005).  Studies that used the MLHFQ 
vary in their interpretation of a clinically meaningful worsening or improvement of 
scores.  Small groups of patients reporting they felt markedly (i.e., improvement of score 
by 21 points), moderately (i.e., improvement of score by 14 points), or mildly (i.e., 
improvement of score by 12 points) improved had significant changes in their scores.  
Patients that reported they were feeling slightly worse had an average worsening of their 
score by 3 points.  The differences between NYHA classes equated to a 16-point 
difference on the MLHFQ (Rector, 2005). 
Summary.  There are multiple factors that affect the QOL of patients with HF 
including symptom distress, comorbidities, functional capacity, psychological factors, 
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NYHA Classification, age, and self-care performance.  HF symptoms may lead to 
functional limitations which negative affects QOL.  Some symptoms that may limit ADL 
functioning and negatively impact QOL include drowsiness, fatigue, and shortness of 
breath.  In addition to these physical symptoms, psychological factors are also a strong 
influence.  Studies have shown that successful self-care performance may diminish 
symptom distress, improve functional capacity, and therefore enhance QOL.  The 
MLHFQ have shown to be reliable and valid in measuring the QOL of patients with HF.       
Summary  
Heart failure is a growing and costly health problem in the United States.  
Advancements in medical science have not prevented frequent exacerbations or hospital 
readmissions.  The reason for this may be a deficiency in heart failure self-care strategies 
by patients.  Literature review has shown that self-care is the most important aspect of 
disease management.  Self-care is characterized by self-care maintenance and 
management activities.  Self-care maintenance includes treatment adherence and 
symptom monitoring.  Health diaries may be useful in recording and improving self-care 
maintenance.  Self-care management involves the process of recognizing symptoms, 
taking appropriate action, and re-evaluating the effectiveness.  Adequate self-care 
performance may be key to preventing frequent exacerbations and hospital readmissions. 
Heart failure diagnosis is attributed to a diminished quality of life for patients.  
HF symptoms impair patients’ abilities to function with ADL.  Impaired functional 
capacity is directly related to QOL.  Studies have shown that successful self-care 
performance may diminish symptom distress, improve functional capacity, and therefore 
enhance QOL.  The study hypothesizes that the use of a heart failure diary will improve 
self-care and quality of life for patients with heart failure.   
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Chapter Three: Methodology   
The purpose of this one group pretest-posttest study design was to determine the 
effect of using a health diary on self-care and QOL for patients with HF.  The study used 
a non-randomized convenience sampling of patients receiving treatment at the outpatient 
HF Clinic.  Non-randomization was achieved by assigning a code number by order of 
participation.  The intervention included individualized education, provision of a HF 
diary, and weekly follow-up.  The effects of the intervention were determined by 
comparing the participants’ pre/post intervention responses to questionnaires, which 
measured self-care and QOL of patients with HF.  The literature review suggests that 
self-care maintenance activities (i.e., symptom monitoring and treatment adherence) 
improved overall self-care performance and QOL for patients with HF.  The 
methodology chapter presents the study’s recruitment process, sample, setting, data 
collection, instruments, statistical analysis, and protection of human subjects.   
Recruitment Process 
The target population included individuals participating at an outpatient HF Clinic 
in northeast Florida.  Upon the University of North Florida Institutional Review Board 
(IRB) (see Appendix A) and hospital Institutional Review Committee (IRC) (see 
Appendix B) approval, study participants were recruited over a period of two weeks at 
the HF Clinic. A verbal group presentation was made and a letter (see Appendix C) 
describing the study and a copy of the Informed Consent (see appendix D) was provided 
for those interested.  A total of 31 patients were available for the presentation, 17 
volunteers signed the consent, and 14 individuals actually participated in the study.   
Population 
The study consisted of a one group non-randomized convenience sample, totaling 
14 volunteers.  The inclusion criteria were diagnosis of HF, any gender, over the age of 
21 years, and any ethnicity.  The ability to read, write, and speak English was also an 
inclusion criteria.  A self-confirmation of HF diagnosis, length of diagnosis, length of 
participation at the HF Clinic, age, gender, and ethnicity was established on the 
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demographic form (see Appendix E).  Individuals legally blind, deaf, cognitively disabled 
(e.g., confusion, dementia, or Alzheimer’s Disease) or physical disabilities (e.g., inability 
to write and stand up independently on a scale) were not included in this study.   HF 
Clinic participants were mostly geriatric patients with multiple comorbidities.  According 
to all the participants, their doctors referred them to the clinic due to frequent HF 
exacerbation hospitalizations.  
Setting 
The setting was an outpatient HF Clinic in northeast FL.  The clinic consists of 
eight recliners with individual cardiac monitors, television with headset, and curtain for 
privacy.  Some patients receive weekly or biweekly inotrope infusion (i.e., cobutamine, 
milrinone), for an average duration of six hours.  Other patients receive an intravenous 
bolus of a diuretic (e.g., furosemide or bumatadine), for an average duration of 30 
minutes.  The clinic is staffed with three registered nurses and a nursing assistant.   
Tools 
Self-Care of Heart Failure Index.  The Self Care of Heart Failure Index 
(SCHFI) (see Appendix F) was used in this study to measure self-care adequacy.  It 
consists of three separate sections of self-care maintenance, self-care management, and 
self-care confidence (Riegel, Lee, Dickson, & Carlson, 2009).  This instrument uses a 
Likert scale for self-report of HF self-care achievement (Riegel et al., 2004).  The 
numerical values range from 1-4, depending on the frequency of self-care maintenance 
activities.  For the purpose of the study’s focus on self-care maintenance, only Section A 
of the SCHFI questionnaire was used.  The SCHFI was published in the Journal of 
Cardiovascular Nursing in 2009, placed in the public domain by the authors, and 
therefore permission for use was not required (Riegel et al., 2009).  The self-care 
maintenance section of the SCHFI has a low coefficient alpha, α = .597.  The validity of 
the SCHFI was assessed qualitatively and quantitatively through several studies discussed 
in the literature review section.  Each patients SCHFI scores were measured pre and post 
intervention.  The effect of the intervention on self-care was determined by calculating 
the difference between the pre and post intervention SCHFI scores.    
Minnesota Living with Heart Failure Questionnaire.  The Minnesota Living 
with Heart Failure Questionnaire (MLHFQ) was used in this study to measure QOL (see 
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Appendix G).  The questionnaire consists of 21 items in a 6-point Likert format, ranging 
from 0-5.  It requires patients to indicate on a 6-point scale (i.e., 0: no, 1: very little, and 
5: very much) how each question prevents them from living as they wish, over the past 
four weeks (Rector, 2005).  The questions reflect the four factors affecting QOL for 
patients with HF including physical, emotional, social, and mental states (Rector, 2005).  
Permission for use was granted on May 31, 2009 (see Appendix H1-H4).  The MLHFQ 
consistently demonstrates a satisfactory level of reliability, > α = .80.  Validity has been 
determined in several studies, as discussed in the literature review section.  Each patients 
MLHFQ scores were measured pre and post intervention.  The effect of the intervention 
on QOL was determined by calculating the difference between the pre and post 
intervention MLHFQ scores.     
Heart Failure Diary.  This investigator developed the Heart Failure Diary (see 
Appendix I1-I3) that was used in this study.  The ledger, journal, daily, and retrospective 
diary designs were all incorporated into the HF diary.  The diary was formatted for 
patients to record their daily weight, weight gain/loss, fluid intake, salt intake, shortness 
of breath, swelling, and medication adherence.  These are common self-care instructions 
given to patients with HF.  The diary was a folder containing four weeks’ worth of 
recording, each week separated by a tab and a cover page with the PI’s contact 
information.  Each section includes an area for totaling weekly weight gain/loss and note 
taking.  Individuals were encouraged to record any questions or concerns they may have 
in the diary, so that it may be discussed during their follow-up with the PI.  Participants 
were instructed to record in the HF diary over a four-week period.  They were instructed 
to record their weight in the morning and other entries at the end of the day.  For visual 
assistance, each day was a different color.  A visual analogue scale (VAS) and visual 
interval scale (VIS) was used for ease of recording and to give patients the freedom to 
express their responses without assumed influence from the investigator or the design of 
the instrument. 
Visual analogue scales have been used in many studies, appearing in the majority 
of pain and mood literature, since the 1960s (Wewers & Lowe, 1990).  Patients are 
instructed to record their daily weight in pounds.  A daily weight gain was logged by 
circling a positive value (i.e., +1 to +5) on the HF diary VIS.  A daily weight loss was 
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logged by circling a negative value (i.e., -1 to -5) on the HF diary VIS.  Patients circled 0 
if there was no change in their weight.  A VAS format was used to measure fluid intake, 
salt intake, shortness of breath, and medication adherence.  Patients were required to 
record their responses between two extremes.  For fluid intake, the range was between 
‘no fluid’ to ‘lots of fluid’.  For salt intake, the range was between ‘no salt’ to lots of 
salt’.  For shortness of breath, the range was ‘no shortness of breath’ to very ‘short of 
breath’.  For swelling, the range was ‘no swelling’ to lots of swelling’.  For taking 
medications, the range was ‘no meds’ to ‘all meds’.  Specific and individual diary entries 
will not be used for statistical analysis.  The effects of keeping and logging in the HF 
diary entry will be determined by summarizing the difference between the pretest-posttest 
SCHFI and MLHFQ scores.   
Data Collection 
The primary investigator (PI) conducted all the steps of the study procedures.  
After the recruitment process, those willing to volunteer in the study contacted the PI.  A 
UNF IRB and hospital IRC Informed Consent (see Appendix B) were completed prior to 
the start of the intervention.  The study procedures were categorized into weekly 
interventions. For convenience, the majority of the interventions were performed at the 
HF Clinic during the patients’ scheduled treatment.  For those not present, follow-up was 
made via telephone. The total duration of the study was between five and six weeks, 
depending on each patient’s weekly or biweekly schedule at the clinic.  
Week One.  It was necessary that the first week of the intervention be conducted 
at the HF Clinic.  For privacy, the individual curtains were closed unless requested 
otherwise.  Each participant completed a demographic form, Self Care of Heart Failure 
Index (SCHFI) questionnaire (see Appendix D), and a Minnesota Living with Heart 
Failure Questionnaire (MLHFQ) (see Appendix E).  After the completion of the 
demographic form and questionnaires, participants were given individualized patient 
education using “Heart Failure: A Patient Guidebook” (see Appendix K) (Baptist 
Medical Center, n.d.).  Each participant was provided and instructed on the Heart Failure 
Diary (see appendix I1-I3) developed by the PI.   
Week Two.  Some participants were not scheduled for treatment at the clinic 
during week one of the study intervention.  These participants completed the 
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demographic form, answered questionnaires, received patient education, and instructed 
on the use of the Heart Failure Diary during week two.  For the remaining participants 
that were present on week one, they received follow-up either at the clinic or by 
telephone.  Follow-up consisted of assisting participants to calculate their total weekly 
weight loss/gain.  The PI also discussed any questions or concerns with each patient.  
Week Three and Four.  During week three to week four, the PI followed-up with 
participants at the HF Clinic during their scheduled treatment time.  However, those that 
were not available at the clinic were followed-up through a telephone call.  
Week Five and Six.  The study intervention concluded during these two weeks.  
For participants available on week one of the study intervention, week five was their final 
week of participation.  First, the PI assisted patients to calculate their weekly weight 
gain/loss and discussed any questions.  Second, each individual’s Heart Failure Diary was 
collected.  A copy of the diary was provided upon request.  Third, each participant 
completed the MLHFQ and SCHFI questionnaires.  After completion of the 
questionnaires, the PI reviewed with each participant their before/after scores and 
discussed any questions.  Fourth, participants voluntarily completed an Evaluation Form 
(see Appendix J).  The PI then provided participants with a letter thanking them for their 
participation (see Appendix K).   For participants not present at the clinic during week 
five, their participation concluded on week six. 
Statistical Analysis 
Analysis of the data was conducted using the SPSS v18 software.  The 
significance, p, of the difference between the questionnaires’ (i.e., SCHFI and MLHFQ) 
total scores and individual question responses were analyzed using the paired t-test.  The 
correlation between demographic data and total scores were determined by estimating the 
Pearson product-moment correlation coefficient, r.   
Protection of Human Subjects 
The UNF IRB and hospital IRC determined the protection of human subjects by 
approving the study protocol in its entirety (see Appendix A and B).  Access to medical 
records (e.g., patient charts) was not necessary.  A portable locking file tote was used for 
transportation and storage, prior to the scanning of documents. After scanning, all forms 
were shredded.  All documents were stored into a secure password protected UNF server 
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in separate folders.  Each folder was also protected with individual passwords.  Only the 
PI had access to the UNF server.   
Patient identifiers (i.e. name, phone number, and participant number) were 
included on the informed consent and master list (see Appendix L).  Participants provided 
their phone number on the Informed Consent, to be used by the PI for follow-up.  The 
information on the Master List included participant number, name, and phone number.  
These documents were separated from the patient response forms at all times.  Each 
patient was assigned a non-randomized, by order of participation, participant number.  
The participant numbers, placed in the document header, corresponded to participant 
response forms (i.e., Demographic Form, SCHFI, MLHFQ, and HF diary).  The 
evaluation form did not include identifiers or participant numbers, it was also scanned 
into the server and then shredded.  After completion of data collection and analysis, all 
documents stored in the UNF server were deleted forever.   
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Chapter Four: Results       
The purpose of the study was to determine the effects of using a HF diary on self-
care and QOL.  This investigator hypothesized an improvement in self-care and QOL of 
patients with HF after the use of a diary.  The intervention included individualized HF 
education, provision of a HF diary, and weekly follow-up.  The length of the intervention 
was a total of five weeks for each participant.  The intervention effects were calculated by 
comparing pretest-posttest SCHFI and MLHFQ scores with paired sample T-testing.  A 
total of 14 patients participated in the study.    
Demographic Data 
The study sample consisted of 14 participants.  The average age of study 
participants ranged from 39 to 72 years, with a mean of 62.357 (9.620) years.  The 
average length of diagnosis ranged from six months to three years, with mean of 5.25 
(4.99) years.  The length of HF Clinic participation ranged from three months to three 
years, with a mean of 2.20 (3.422) years.  There were an equal number of males/females 
(i.e., 7) and Caucasians/African Americans (i.e., 7).  The Caucasian group consisted of 
four women and three men.  The African American group consisted of three women and 
four men. 
Self-Care of Heart Failure Index 
Total Scores.  The total score for the self-care maintenance (i.e., Section A) 
portion of the SCHFI was recalculated for a 100-point scale by the formula, (sum of 
Section A items – 10) 3.333, as recommended by the developers Riegel et al. (2009).  
The minimum score is 10 and the maximum 100, with >70 considered adequate self-care 
maintenance. The effects of the intervention were calculated by subtracting the posttest 
from the pretest scores.  An improvement in self-care maintenance is represented by a 
positive value of the difference (e.g., 5).  A decline in self-care maintenance is 
represented by a negative value of the difference (e.g., -5).   
The participants, n = 14, completed the SCHFI questionnaire prior to and after the 
intervention.  There were minimal differences between the pretest-posttest scores for 
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most of the participants (see Figure 4).  The mean pretest score was 64.459 (9.291), SE = 
2.483.  The mean posttest score was 67.076 (13.565), SE = 3.625.  The difference 
between the mean pretest-posttest scores were, 2.616 (12.942), SE = 3.459.  The 
difference in pretest-posttest scores resulted in a minimal improvement of self-care 
maintenance adequacy, but according to the paired sample t-test was not significant, p = 
.463, t = -.756, 95% CI [-10.089, 4.856]. Additionally, the paired sample test of the 
participants’ total pretest and posttest scores were not significantly correlated, r = 0.408, 
p = 0.148.  For example, a high or low pretest score did not determine the posttest score. 
 
 
Figure 4.  Comparison of the Self-Care of Heart Failure Index total scores for each 
participant, pre-intervention and post-intervention, demonstrates insignificant change.  
 
Individual Question Analysis.  The significance of the difference from pretest-
posttest responses, for each individual question of the SCHFI, was analyzed using paired 
t-test (See Table 1).  Questions 3 (i.e., avoiding sick people), 4 (i.e., doing physical 
activity), 5 (i.e., keeping provider appointments), 7 (i.e., exercising for 30 minutes), and 9 
(i.e., asking for low salt items) were significantly positively correlated, meaning pretest 
and posttest responses were associated in such a way that low pretest scores were 
associated with low posttest scores and high pretest scores associated with high posttest 
scores.  That is, the individual posttest responses to these questions were similar to the 
pretest.  There was borderline correlation between the pretest and posttest response for 
question 1 (i.e., weighing yourself).  The paired sample analysis did not show a 
significant difference between the pretest and posttest responses, for each individual 
question (see Figure 5).  
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Table 1 
Self-Care of Heart Failure Index Individual Question Analysis 
Question Mean SD SEM r (p) t p 
1 -.286 .726 .194 .523 (.055) -1.472 .165 
2 -.071 .730 .195 .349 (.221) -.366 .720 
3 -.286 .726 .194 .776 (.001)** -1.472 .165 
4 -.071 .730 .195 .629 (.016)* -.366 .720 
5 .000 .392 .105 .679 (.008)* .000 1.000 
6 .500 .941 .251 .452 (.105) 1.989 .068 
7 -.071 .616 .165 .826 (.000)** -.434 .671 
8 -.143 1.231 .329 -.085 (.771) -.434 .671 
9 -.286 .726 .194 .750 (.002)* -1.472 .165 
10 -.071 .730 .195 .667 (.009) -.366 .720 
Note: Comparing the correlation, r (p), and the difference, p, between each individual question for all 
participants (n = 14, df = 13). 
*p < .05,  ** p < .001. 
 
 
Figure 5.  Comparison of the Self-Care of Heart Failure Index pretest and posttest mean 
responses for each question, demonstrates non-significant change. 
 
 
 
Demographic Correlations.  The difference between the pretest-posttest total 
mean scores was analyzed for correlation with demographic data (i.e., age, gender, 
ethnicity, length of diagnosis, and length of participation at the HF Clinic).  There was 
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not a significant correlation with age, r = .090, p = .759; gender, r = -.080, p = .787; 
length of diagnosis, r = .083, p = .777; or length of participation at the HF Clinic, r = 
.326, p = .255.   
There was a strong correlation between the difference in total pretest-posttest 
mean score and ethnicity, r = .782, p = .001.  This was further analyzed by paired sample 
testing of the pretest minus posttest score differences (see Table 2).  A negative value 
represents improvement.  A positive value represents worsening.  The total scores for 
Caucasian patients improved by a mean of 12.379 points and statistically significant, p = 
.003.  The total scores for the African American patients declined by an average of 7.142 
points, but not statistically significant, p = .105.   
 
Table 2 
Self-Care of Heart Failure Index Score and Ethnicity Correlation 
Ethnicity Mean SD SEM 95% CI t p 
Caucasian -12.379 6.586 2.489 -18.470, -6.288 -4.973 .003* 
African American 7.142 9.892 3.739 -2.007, 16.291 1.910 .105 
Note:  *p < 0.05. 
 
 
 
Figure 6.  Comparison of the Self-Care of Heart Failure Index difference in pretest-
posttest mean responses for each question, demonstrates a contrast between the African 
American and Caucasian ethnic groups.  Further demonstrating the significant 
improvement of self-care adequacy in the Caucasian compared to the African American 
group.   
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Minnesota Living with Heart Failure Questionnaire  
Total Score. The MLHFQ scoring system is based on a 100 points scale, with a 
minimum score of 0.  An increase in total score represents a worsening in quality of life, 
and a decrease for improvement.  The intervention effect was calculated by subtracting 
the posttest from the pretest score.  An improved HF QOL is represented by a negative 
value (e.g., -5) of the difference.  A worsened HF QOL is represented by a positive value 
(e.g., 5) of the difference.   
 Participants, n = 14, completed the MLHFQ questionnaire prior to and after the 
intervention.  There were minimal changes between the total pretest and posttest scores 
for most of the participants (see Figure 5).  The mean pretest score was 57.29 (28.253), 
SE = 7.551.  The mean posttest score was 51.79 (26.635), SE = 7.118.  The difference 
between the mean pretest-posttest scores were, -5.500 (18.851), SE = 5.038.  The 
difference in pretest-posttest scores resulted in a slight improvement in HF QOL, but 
according to the paired sample test was not significant, p = .295, t = 1.092, 95% CI [-
5.384, 16.384].  Additionally, the total pretest and posttest scores were highly positively 
correlated, r = 0.77, p = 0.001.  Meaning, those who scored a high pretest score also 
scored higher on the posttest.      
  
 
 
Figure 7.  Comparison of the Minnesota Living with Heart Failure Questionnaire pretest 
and posttest scores for each participant demonstrates improvement in QOL, but 
insignificant.  
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Individual Question Analysis.  The significance of the difference from pretest-
posttest responses, for each individual question of the MLHFQ, was analyzed using 
paired t-test (Figure 8 and Table 3).  The pretest and posttest responses were significantly 
correlated for questions 1 (i.e., causing swelling), 3 (i.e., making walking and climbing 
stairs difficult), 4 (i.e., making working around the house and yard difficult), 5 (i.e., 
making going away from home difficult), 7 (i.e., making relating to or doing things with 
friends/family difficult), 9 (i.e., making recreation, hobbies, and sports, difficult), 12 (i.e., 
making you short of breath), and 14 (i.e., making you stay in the hospital).  Meaning, 
pretest and posttest responses were associated in such a way that low pretest scores were 
associated with low posttest scores and high pretest scores associated with high posttest 
scores.  For question 9, the paired sample analysis showed a significant pretest-posttest 
difference, p = .029, and correlation, r = .573, p = .032.  For question 8, it also showed a 
borderline significant pretest-posttest difference, p .063, but no significant correlation. 
 
 
 
Figure 8.  Comparison of the MLHFQ pretest and posttest mean responses for each 
question, demonstrates mostly insignificant change, except for question 8 and 9 of which 
could be due to chance since there were 21 tests performed at the 5% level of 
significance. 
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Table 3 
Minnesota Living with Heart Failure Questionnaire Individual Question Analysis  
 Mean SD SE r (p) T p 
1 .42857 1.74154 .46545 .555 (.039)* .921 .374 
2 -.14286 1.91581 .51202 .269 (.352) -.279 .785 
3 -.14286 1.35062 .36097 .661 (.010)* -.396 .699 
4 .14286 1.35062 .36097 .686 (.007)* .396 .699 
5 -.07143 154244 .41223 .670 (.009)* -.173 .865 
6 .42857 2.47182 .66062 .094 (.750) .649 .528 
7 .14286 1.46009 .39023 .609 (.021)* .366 .720 
8 1.14286 2.10703 .56313 .480 (.083) 2.029 .063 
9 1.14286 1.74784 .46713 .573 (.032)* 2.447 .029* 
10 .57143 2.50275 .66889 .394 (.164) .854 .408 
11 -.21429 2.04483 .54650 .389 (.170) -.392 .701 
12 .14286 1.16732 .31198 .717 (.004)* .458 .655 
13 -.07143 1.89997 .50779 .513 (.061) -.141 .890 
14 -.14286 1.23146 .32912 .811 (.000)** -.434 .671 
15 .28571 2.61441 .69873 .166 (.570) .409 .689 
16 .57143 1.69680 .45349 .595 (.025)* 1.260 .230 
17 -.14286 1.09945 .29384 .877 (.000)* -.486 .635 
18 .57143 1.60357 .42857 .671 (.009)* 1.333 .205 
19 .64286 2.13423 .57049 .525 (.054) 1.127 .280 
20 -.14286 1.83375 .49009 .473 (.087) -.291 .775 
21 .35714 .84190 .22501 .921 (.000)* 1.587 .136 
Note: * p = < .05, ** p = < .001. 
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Demographic Correlations.  The change in pretest-posttest scores was not 
significantly different when stratified by race, t = -0.287, p = 0.779, or gender, t = -1.294, 
p = 0.220.  The Caucasian group had a 7-point improvement with their HF QOL score 
and the African American group had a 4-point improvement.  Unlike the SCHFI, both 
ethnic groups had a slight improvement with their HF QOL, but statistically non-
significant, p = .295.  Change in score did not correlate with length of diagnosis, t = -
0.206, p = 0.480, or length of participation at the HF Clinic, t = 0.048, p = 0.869.  
The relationship between the pretest-posttest score difference and age was 
moderately positively correlated, t = 2.450, p = .031, 95% CI [.006, .102].  However, if 
the youngest patient who was 39 years old were removed, the moderate positive 
correlation with age would not exist. 
Summary 
Heart Failure Diary.  Patients were told prior to volunteering, that incompletion 
of the HF diary will not remove them from the study.  However, all of the participants for 
the most part completed their diaries and this may be due to the weekly follow-up.  
Completion or incompletion of the participant’s HF diaries was not used in the data 
analysis.  Specific entries of the HF diary were not used in the statistical analysis.  The 
overall effect of the intervention was analyzed through statistical analysis of the SCHFI 
and MLHFQ pre/post intervention score differences.  
Self-Care of Heart Failure Index.  Each participant’s total pretest and posttest 
scores were mostly inadequate (i.e., < 70) (see Figure 4).  For both the pretest and 
posttest scores, only five participants had adequate self-care scores.  The difference 
between pretest-posttest scores showed a non-significant improvement in self-care 
adequacy, n = 14, 2.616 (12.942), SE = 3.459, p = .463, t = -.756, 95% CI [-10.089, 
4.856].  The paired sample test for the correlation between the pretest and posttest total 
group scores was also non-significant, r = 0.408, p = .148, but this may be due to an 
artifact of the small sample size.   
Individual questions were further analyzed to assess a difference and correlation 
between pretest and posttest responses.  Questions 3, 4, 5, 7, and 9 were significantly 
correlated, meaning pretest and posttest responses were similar.  However, question 9 
(i.e., asking for low salt items) is the only question with significant correlation that is also 
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a HF diary entry.  Question 1 (i.e., weighing yourself), which had a borderline significant 
correlation with the pretest and posttest responses, is also an entry in the HF diary.  
However, the difference from pretest-posttest responses for these particular questions, 
were found to be non-significant.  Therefore, using the HF diary did not affect these 
specific self-care activities (i.e., asking for low salt items and daily weight).  Although 
not included as a HF diary entry, question five (i.e., keeping provider appointments) had 
significant correlation between pretest and posttest responses.  This corresponds with the 
study by Eastwood et al. (2007) that found diary users contacted healthcare providers 
more than non-users.  Again, the difference with question five’s pretest-posttest response 
was not significant.  The HF diary entries were not included in the data analysis and 
therefore these relationships were not further analyzed.   
There was a strong significant difference between ethnic groups.  The Caucasian 
group improved their total score by an average of 12 points post-intervention.  The 
African American group had a decline in their total score by an average of 7 points post-
intervention.  The average age for both ethnic groups was 62 years.  There was a 
difference between the mean length of HF diagnosis for the African American group, 
6.071 (4.891) years, compared to the Caucasian group, 4.428 (5.341) years, however this 
was statistically not significant, t = .60, p = .559.  There was also a difference between 
the mean length of participation at the HF Clinic for the African American group, 3.535 
(4.5355) years, versus the Caucasian group, 0.857 (0.788) years, however this was also 
statistically not significant, t = 1.54, p = .172.   Although the difference in these means 
were observed, it was not statistically significant.  There are contradicting information in 
the literature regarding symptom awareness and the length of diagnosis.  For those who 
have been diagnosed with HF longer, their symptom awareness may be strong because of 
their past experience with exacerbations or they may be unmoved by slight changes in 
their health status by accepting it as ‘part of life’ or ‘part of getting old’.  Evidence 
suggests that HF clinics improve patient outcomes through frequent monitoring and 
reinforcement, however whether attendance may cause the patients’ to rely more on the 
clinic than themselves is unknown.  The completion/incompletion and specific entries of 
the HF diary were not included in the data analysis, but would be interesting to further 
analyze the difference between the ethnic groups. 
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Minnesota Living with Heart Failure Questionnaire.  The one-group sample’s, 
n = 14, pretest total mean score, 57/105, improved by 5 points, 52/105.  The difference in 
the MLHFQ pretest-posttest scores demonstrates a non-significant improvement of HF 
QOL, n = 14, -5.500 (18.851), SE = 5.038, p = .295.  However, the relationship between 
the pretest and posttest scores were highly positively correlated, r = .77, p = .001.  
Meaning, those who scored high on the pretest also scored high on the posttest.  The 
difference in the group pretest-posttest scores did not have a significant correlation with 
the demographic data (i.e., race, gender, length of diagnosis, and length of participation at 
the HF Clinic).  Unlike the SCHFI, both ethnic groups had an improvement with their 
QOL scores, but not statistically significant, t = -.287, p = .779.  The moderate positive 
correlation between age and MLHFQ scores was not meaningful because when the 
youngest patient (i.e., 39 years) was removed from the sample data the correlation was 
nonexistent.    
The MLHFQ individual question analysis showed significant pretest and posttest 
response correlations between questions 1, 3, 4, 5, 7, 9, 12, 14, 16, 17, 18, and 21. The 
majority of these questions can be categorized into the physical subscale of the MLHFQ 
and may be related to the severity of symptoms and treatment adherence.  Questions 1 
(i.e., swelling) and 12 (i.e., shortness of breath) are entries in the HF diary, for symptom 
monitoring.  Question 16 (i.e., treatment side effects) is relatable to the medication 
adherence entry on the HF diary, since side effects may cause patients to be 
noncompliant with their treatments.  Question 9 (i.e., making recreational pastimes, 
sports, and hobbies difficult) had a significant difference in pretest-posttest response, t = 
2.447, p = .029.  Question 8 was borderline significant with the difference in pretest-
minus posttest response, t = 2.029, p = .063.  However, due to the multitude of questions, 
21, the significance of questions 8 and 9 may be due to chance.   
Null Hypothesis Retained.  Paired T-testing did not show a significant difference 
between the total pretest-posttest scores and individual question responses, therefore the 
null hypothesis is retained.  According to this study’s non-significant difference in the 
SCHFI or MLHFQ scores, the use of a diary did not improve self-care or QOL of the 
patients with HF.  The use of a diary did not improve the self-care or quality of life of 
patients with HF.  Nonparametric testing for each the individual questions, using 
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Wilcoxin signed rank test, had similar results with the Paired t-test confirming that the 
null hypothesis was retained.  The effect size of the SCHFI, d = .20, and the MLHFQ, d 
= .29, are both small and most likely due to the small sample size. 
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Chapter Five: Discussion 
As stated by the ACCF/AHA, close observation and follow-up is the most 
effective and unfortunately least used measure in HF treatment (AHA, 2009).  In order to 
decrease hospitalization admission rates and lower costs, hospitals designated specific 
outpatient HF clinics to closely monitor those with frequent exacerbations.  According to 
Eastwood et al. (2007) diary users were more likely to attend these clinics than non-users. 
Self-care is a vital aspect of HF disease management, ultimately determining a negative 
or positive outcome. There is strong evidence of the correlation between self-care and 
quality of life in the literature.  As providers, we need to continue to develop 
interventions that encourage and empower patients to take control of their disease 
process.  The objective of this study was to determine whether the use of a diary 
improved the self-care or quality of life of patients with HF. 
The concept of developing a HF diary was based on the multitude of self-care 
instructions (i.e., weight monitoring, fluid restriction, low sodium diet, exercise, 
medication adherence, and symptom monitoring) given to patients diagnosed with HF.  It 
requires a change in lifestyle that can be viewed as cumbersome and others may be 
resistant to a deviation from their norm.  A HF diary may be beneficial as a guide and 
reminder for patients to perform daily self-care activities.  The diary may also be useful 
as a reference for patients and providers to monitor trends.   
To determine if the HF diary is a useful tool in practice, its effects on self-care 
and quality of life was determined by comparing the SCHFI and MLHFQ scores pre and 
post intervention.  The SCHFI self-care maintenance (i.e., Section A) was chosen because 
the HF diary entries (i.e., symptom monitoring and treatment adherence) specifically 
relate to the individual questions.  The MLHFQ was used because of its high reliability, 
adequate validity, and it is commonly used in HF related research.   
The one-group pretest/posttest study design included patients with a mean age of 
62 years, equal number of males/females, equal number of African Americans versus 
Caucasians, average length of diagnosis was five years, and average HF Clinic 
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participation was two years.  Prior to the intervention, the SCHFI scores were mostly 
inadequate (i.e., 70) and the MLHFQ averaged in the middle of the 100-point scale.  The 
SCHFI pre-post intervention score differences resulted in a non-significant improvement 
of self-care maintenance n = 14, 2.616 (12.942), SE = 3.459, p = .463.  The MLHFQ pre-
post intervention score differences resulted in a non-significant improvement of QOL, n 
= 14, -5.500 (18.851), SE = 5.038, p = .295.  In regard to demographics, there was a 
strong significant correlation between the difference in total pretest-posttest scores and 
ethnicity, r = .782, p = .001.  The Caucasian group had a significant improvement of self-
care maintenance adequacy, p = .003.  The African American group had a non-significant 
decline of self-care adequacy, p = .105.  The QOL measure did not show a significant 
difference with regard to ethnicity.    In conclusion, the use of a diary did not improve the 
self-care or quality of life of these patients with HF.   
Limitations 
Significant differences may be observed with a larger sample, such as a change in 
scores and demographic correlations.  The demographic data was limited and should have 
included other predictors of self-care (i.e., comorbidities, NYHA Class, and educational 
level).  This data may also be used as inclusion and/or exclusion criteria.  Determining 
NYHA Class and comorbidities would have required access to participants’ medical 
records.  A greater duration of the study intervention may have had greater impact and 
significant change of scores.   
The SCHFI self-care maintenance subscale has a low coefficient alpha and the 
reverse scoring for question 8 (i.e., forget to take one of your medications) complicates 
the investigator’s calculations and participants’ responses.  There is random error present 
in both questionnaires (i.e., SCHIF and MLHFQ), which is present in all instruments.  
Analysis of the specific HF diary entries (i.e., completion/incompletion, weight changes, 
symptom severity, monitoring adequacy, and treatment adherence) may have provided 
greater information on their effects on self-care and QOL.   
Exercise should have been added as a diary entry, as it is strongly encouraged for 
patients with HF.  The initial plan was to include only symptom monitoring activities in 
the diary.  When the decision was suggestion was made to include medication adherence, 
the investigator mistakenly forgot to include exercise.  This investigator recognizes the 
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major flaw of not including exercise as a diary entry, which is encouraged and 
emphasized in HF management.    
Randomization, with a control and experimental group, would further prevent bias 
and determine a significant difference between diary users and nonusers.  The 
investigator’s past experience in caring for these patients in the HF Clinic was an existing 
bias.  During the whole duration of this study, the investigator’s role was only of a 
student researcher.  The investigator’s past history with study participants may have 
influenced their decision to participate, responses to the questionnaire, and completion of 
the HF diary.   
Implications for Further Study 
The HF diary entries included symptom monitoring (i.e., weight changes, 
shortness of breath, and swelling) and treatment adherence (i.e., fluid intake, salt intake, 
and medication adherence).  Further data analysis may focus on the HF diary entries’ 
(i.e., individual entries and level of completion) effect on self-care adequacy and QOL.  
Predictors of self-care adequacy and QOL (i.e., comorbidities, education level, and 
NYHA classification, functional capacity, emotional/mental state, socioeconomic, and 
social support) may provide additional information.  Future studies can investigate 
healthcare disparities, including the ethnic variance in self-care adequacy.  Beyond self-
care maintenance, the benefits of the HF diary may be assessed in regard to self-care 
management and confidence.  The VAS format may continue to be used in the diary 
design, because the point of entries can be quantified with a measurement ruler.  Doing 
so, may further determine each participants’ level of symptom severity and treatment 
adherence.   If proven to be beneficial, the diary may be useful to reinforce HF patient 
education and management.   
Implications for Nursing Practice 
Nurse practitioners are employed in a variety of areas in the healthcare industry.  
Primary care nurse practitioners are involved in the care and management of patients with 
HF.  In these settings, there may be minimal time allotted for education and 
reinforcement.  Tools, such as a HF Diary, may be beneficial in expediting education and 
empowering patients.  A diary may also serve to assess adherence, reinforce self-care, 
evaluate adequacy, monitor trends to prevent exacerbations, and assist in improving 
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QOL.  Nurse practitioners must continue researching ways to incorporate education and 
health promotion into their daily practice that will attract interest and simplify adherence.      
Summary 
As healthcare costs continue to rise, there needs to be greater focus on preventing 
illness and its complications.  It is more costly to develop new drugs and technology than 
allowing time to provide appropriate education and reinforcement.  Healthcare providers 
must continue to be creative in encouraging patients to feel empowered in taking control 
of their health.   
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Appendix B 
Hospital IRC Approval 
 
 
Institutional Review Committee 
September 13, 2010 
Claudette Walker, BSN, RN 
 
RE: .#10-44, University of North Florida, "Effects of the Use of a Heart Failure Diary on 
Self-Care and Quality of Life". 
-Protocol Submission Checklist; summary letter; UNF IRB Approval dated 16 August 
2010; Protocol, revision July 2009; Consent document, version date 16 August 2010; 
Financial Disclosure forms; Heart Failure Diary. 
 
Dear Ms. Walker: 
The Institutional Review Committee (IRC) of Baptist Medical Center (BMC) met on 
September 9, 2010, and the aforementioned new protocol was reviewed and approved via 
Expedited Review for a period of one year.   
The anniversary date for this study is September 8, 2011.  At that time, please submit a 
report of your experiences with this protocol.    
Should you have any questions, please contact the IRC office.  The BMC IRC meets the 
requirements in 21 CFR 56 (Rev.), 45 CFR 46 (Rev.) and ICH (E6) GCP guidelines.  
Good luck with this endeavor. 
                 	  
Chairman Institutional Review Committee 
Signature Deleted
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Appendix C 
Introduction Letter 
Date: July 1, 2010 
Dear HF Clinic Participant: 
My name is Claudette Walker.  I am a Baptist Medical Center RN and a graduate student at the University 
of North Florida School of Nursing.  First, I would like to ‘thank you’ for taking time during your treatment 
session at the HF Clinic to listen to the research study presentation.  I’d like to provide you with the 
information below in considering participation in the research study.   
The title of my research is: Effects of the use of a Heart Failure Diary on Self-Care and Quality of Life.  
The purpose of my study is to examine the effect of a Heart Failure Diary on Self-Care and Quality of Life 
for patients with Heart Failure.  Participation in the study is voluntary and involves completion of an 
informed consent, demographic form, questionnaires, and a HF Diary.  Information required on the 
demographic form includes: diagnosis of Heart Failure (yes/no), length of HF diagnosis (years/months), 
length of participation at the HF Clinic (years/months), age, gender, and ethnicity.  There are two 
questionnaires that will be completed in the beginning and the end of the study.  The first questionnaire is 
called the Self-Care of Heart Failure Index and measures your Heart Failure self-care activities.  The 
second questionnaire is called the Minnesota Living with Heart Failure questionnaire and measures how 
Heart Failure has affected your quality of life.  You will be given individualized education using the Baptist 
Medical Center Heart Failure: A Patient Guide book.  You will also be provided a Heart Failure Diary to 
record your daily weight, weight gain/loss, fluid intake, salt intake, shortness of breath, swelling, and 
medications taken.  I will instruct you on how to use the Heart Failure Diary.  Please try your best to fill out 
the diary every day for the duration of 4 weeks.   
The total duration for participating in the study is 5-6 weeks, each session will take between 15-60 minutes 
of your time.  I will follow-up with you on a weekly basis, during your scheduled treatment day at the HF 
Clinic or by telephone.  You will be provided with my contact information in case you have any questions 
or concerns throughout the study process.  
There are no anticipated or potential social, legal, employment, or financial risk for you to participate in the 
study.  The foreseeable risks include feeling ‘tested’ when completing questionnaires and distracted 
because of the group setting.  There is also a risk that you may feel pressured to participate by thinking that 
your refusal will affect the level of care received or opinions held by the HF Clinic staff.  Remember that 
participation is voluntary and will not change any treatment or care that is being provided by the HF Clinic 
staff.  You may feel pressured to fully complete all sections of the HF Diary, however not being able to 
fully complete the diary will not have any negative consequences.  The cost of the study is your time, 
however the majority will be done at the HF Clinic during your scheduled treatment day or by telephone.   
Please contact me of any further questions you may have regarding the study.  I hope you will consider 
volunteering and participate in the research study.   
Sincerely, 
Claudette Walker RN BSN 
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Appendix D1 
Informed Consent 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires:09/09/2011 
 
INFORMED CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
This form explains the research. This form also lists the information about you that will 
be obtained during the study, how it will be used, and with whom it will be shared. You 
should understand the study well before you agree to participate. The people in charge of 
the study will answer your questions about it at any time. We encourage you to ask 
questions and take the opportunity to discuss the study with anybody you think can help 
you make this decision. 
 
1.  WHAT IS THE TITLE OF THE STUDY? Effects of the use of a heart failure diary 
on self-care and quality of life 
2.  WHO IS IN CHARGE OF THE STUDY AT BAPTIST MEDICAL CENTER? 
Principal Investigator: Claudette Walker RN BSN  
Address: Jacksonville Beach, FL 32250 
Phone #: H (904) 241-0939 C (904) 403-7231 
Co-Investigators: Katherine Robinson, RN, PhD  
University of North Florida 
(904) 620-1459  
Research Coordinator: Claudette Walker RN BSN 
Contact Information: 
Phone: (904) 403-7231  
Email: claudettewalker@gmail.com 
 
3.WHO SHOULD RESEARCH PARTICIPANTS CONTACT ABOUT THEIR 
RIGHTS? 
Chairman, Baptist Medical Center Institutional Review Committee at (904) 202-2127. 
Dr. Katherine Kasten, Chairperson of University of North Florida IRB (904) 620-2498. 
4.  WHAT IS THE PURPOSE OF THE STUDY? The purpose of this study is to 
determine the effects of using a heart failure diary on self-care and quality of life. 
5.  WHO IS SPONSORING OR PAYING FOR THE STUDY? The University of North 
Florida is the primary sponsor 
 
Version date 8/16/2010Page  1 of 9 
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Appendix D2 
Informed Consent 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires: 09/09/2011 
6.  WILL THE INVESTIGATORS MAKE MONEY FROM THIS STUDY? NO 
 
7.  WHO CAN BE IN THE STUDY? Patients participating in the HF Clinic at Baptist 
Medical Center Downtown, who are over the age of 21 years, speak English as primary 
language, and are able to read and write in English. 
 
8.  HOW MANY OTHER PEOPLE WILL BE IN THE STUDY? 20 
 
9. HOW LONG WILL PARTICIPATION IN THE STUDY LAST? 5-6 weeks depending 
on your HF Clinic treatment schedule. The length of time for each session depends on the 
week: Week 1 (30min-1hour), Week 2 (15- 30min), Week 3 (15-30min), Week 4 (15-
30min), Week 5/Week 6 (30min- 1hour). 
 
10.  WHAT ARE THE RESEARCH PROCEDURES? 
During this study: (curtains will be closed during activities for privacy) 
1) If you volunteer to participate, you will sign an informed consent.  
2) Week 1: 
a) You will complete 2 questionnaires about:  
i) Heart Failure Self-care  
ii) Heart Failure Quality of Life 
b) b.You will complete a demographic form, information required includes: 
i) Have you been diagnosed with Heart Failure (yes/no) 
ii) How long have you had Heart Failure (years/months) 
iii) How long have you been participating at the Heart Failure Clinic? 
(years/months) 
iv) Age (years)  
v) Gender (male/female)  
vi) Ethnicity (Caucasian, African American, Hispanic, Asian, Other)  
c) You will receive one-on-one education about Heart Failure: using the Baptist 
Medical Center Heart Failure: A Patient Guide book  
d) You will be provided and instructed on how to use the Heart Failure Diary 
3) Week 2: 
a) a.We will review the diary together at the HF Clinic or by phone 
b) b. We will discuss any questions/concerns you may have 
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Appendix D3 
Informed Consent 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires: 09/09/2011 
4) Week 3: 
a) We will review the diary together at the HF Clinic or by phone 
b) We will discuss any questions/concerns you may have 
5) Week 4:  
a) We will review the diary together at the HF Clinic or by phone 
b) We will discuss any questions/concerns you may have 
6) Week 5: 
a) We will review the diary together at the HF Clinic  
b) We will discuss any questions/concerns you may have 
c) You will complete the 2 questionnaires again 
i) Heart Failure Self-care  
ii) Heart Failure Quality of Life  
iii) We will review your before and after questionnaire results  
d) You will complete an evaluation form 
e) The diaries will be collected. If you want, you can be given a copy. 
7) Week 6: *if you’re not scheduled for a HF Clinic treatment for Week 5 
a) We will review the diary together at the HF Clinic  
b) We will discuss any questions/concerns you may have  
c) You will complete the 2 questionnaires again 
i) Heart Failure Self-care  
ii) Heart Failure Quality of Life  
iii) We will review your before and after questionnaire results  
d) You will complete an evaluation form 
e) The diaries will be collected. If you want, you can be given a copy. 
 
11.  WHAT ARE POSSIBLE RISKS OF BEING IN THIS STUDY? There are no 
anticipated or potential social, legal, employment, or financial risks for those 
participating in the study. A psychological stress of feeling insecure about being 'tested' 
or feeling distracted, may be experienced during the completion of questionnaires even 
with the individual curtains closed for privacy. The questionnaires are not a 'test' but an 
evaluation of where self-care improvement may be useful. The provided individualized 
education, completion of questionnaires, and completion of diary may be viewed as time 
consuming. However, the majority of the intervention will be carried out during your 
scheduled treatment day at the HF Clinic for convenience, or by telephone. You may feel 
pressured to fully complete all sections of the HF Diary. Not being able to complete the 
diary will not have any consequences. 
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Appendix D4 
Informed Consent 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires: 09/09/2011 
 
12.WHAT ARE POSSIBLE BENEFITS OF BEING IN THIS STUDY? You may benefit 
by learning more about Heart Failure, improving your self- care skills and quality of life. 
 
13.  WHAT HAPPENS IF A PROBLEM OR INJURY RESULTS FROM THE 
RESEARCH PROCEDURES? There are no anticipated problems from participating in 
this study. If you feel there may be a problem or experience injury related to the study, 
contact me and at that time you will be removed from the study. 
 
14.  IS BEING IN THE STUDY VOLUNTARY? Yes and you may request to be 
removed from the study at any point. 
 
15.  WHAT ARE OTHER CHOICES BESIDES BEING IN THE STUDY? You may 
choose to not participate in the study. 
 
16.  CAN THE RESEARCHERS REMOVE SOMEONE FROM THE STUDY? 
Yes. If for any reason the researcher or IRB/IRC administrators feel you are at risk, they 
may choose to stop you from participating in the study. 
 
17.  WHAT ARE THE COSTS OF BEING IN THIS STUDY? No financial costs, except 
for your time spent participating in the study. 
 
18.  WILL PEOPLE BE PAID FOR BEING IN THIS STUDY? No 
Neither I, University of North Florida, or Baptist Medical Center will profit from this 
study. There are no financial ties or interactions with University of North Florida that 
would influence the conduct of this study or the reporting of the results. 
 
19.WILL PEOPLE IN THE STUDY BE TOLD OF ANY NEW INFORMATION THAT 
MIGHT AFFECT THEIR WILLINGNESS TO STAY IN THE STUDY? If any new 
information were to arise (this is not expected), you would be told. 
 
20.  WHAT INFORMATION ABOUT ME WILL BE USED OR DISCLOSED? 
Your medical records will not be accessed during the study. 
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Appendix D5 
Informed Consent 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires: 09/09/2011 
 
The information about you that will be used for the study is: 
 
If you have been diagnosed with Heart Failure 
 
How long you’ve had Heart Failure 
 
How long you’ve been participating at the HF Clinic 
 
Age 
 
Gender (male/female) 
 
Ethnicity (Caucasian, African American, Hispanic, Asia, Other) 
 
Phone Number (this is only used for weekly follow-up) 
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Appendix D6 
Informed Consent 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires: 09/09/2011 
 
Your personal information including name, address, medical record number, social 
security number, and detailed medical history (other than a self reported diagnosis of HF) 
will not be needed for study participation.  You will be assigned a code number which 
will be recorded on each form completed.  There will be a Master List of all participants 
which will include the participant code number, the participant’s name, and telephone 
number.  Upon completion of informed consents, demographic data, SCHFI 
questionnaire, MLHF questionnaire, evaluation forms, and Master List will be 
temporarily stored in a portable locking file tote and then scanned into a password 
protected secure UNF server to ensure maximm participant confidentiality.  The PI will 
complete the Master List on a password protected Laptop, email to a password protected 
UNF email address for backup, and store 
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Appendix D7 
Informed Consent 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires: 09/09/2011 
 
in a UNF secure server separate from participant responses. The Master List will be 
securely stored in a separate location from participant responses at all times on UNF's 
secure server.  The only person who will have access to the Master List is Claudette 
Walker, the PI.  The only identifiers on the HF diary are participant numbers.  At the 
conclusion of the study, HF diary entries will also be stored in the UNF secure server.  
All scanned documents will be shredded. 
 
The results of this study may eventually be presented at meetings or in print.  However, 
your identity will not be disclosed in those presentations.  The results of this project will 
be shared with other researchers and administrators.  Information may be exchanged 
between investigators, but patient confidentiality will be maintained.    
 
All information will be kept confidential.  Your identity will be protected as much .as the 
law permits.  The Sponsor will receive information from this study.  Your research 
records and this signed consent form can be inspected by: 
 
Study Management Program or representative 
The U.S. Department of Health and Human Services 
Baptist Medical Center Institutional Review Committee 
Food and Drug Administration (FDA) 
 
The privacy of your information cannot be guaranteed after it is disclosed, but all 
attempts to maintain your anonymity will be provided.   
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Appendix D8 
Informed Consent 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires: 09/09/2011 
21.  SIGNATURES 
I am making a decision whether or not to participate in the above study.  I have read, or 
had read to me in a language that I understand, all of the above.  I have asked questions 
and received answers about things I did not understand.  I willingly give my consent for 
my participation in this study. 
My signature indicates that I give researchers permission to disclose (release) information 
that identifies me, and health information about me, for this research study.  I understand 
that: 
I can cancel this authorization/consent.  The use and/or disclosure (release) of 
information will stop after the cancellation is received.  Information that is used or 
disclosed before a cancellation may still be used. 
My information may be disclosed again by the person or entity who receives it.  It his 
happens, Federal or State Law may not protect my information. 
I have the right to refuse to sign this authorization. 
If I refuse to sign this authorization, I will not be allowed to be in this research 
study.   
I have the right, in general, to ask the study coordinator to tell me who has 
received by PHI (Protected Health Information).  However, the list would not 
include information that was released for research studies with signed consents. 
I will receive a signed and dated copy of this authorization. 
By signing this informed consent document, I am not waiving any of my legal 
rights. 
 
I consent and authorize Claudette Walker RN BSN to perform upon  
 
__________________________ (Name of Participant) the research described above. 
 
 
____________________________     ___________________________     ____________ 
Name of Participant (Print)                 Signature of Participant                      Date 
(18 years of age or older) 
Participant Phone#  _____________________ 
 
Claudette Walker RN BSN____________________________     ___________ 
Name of Person Administering            Signature of Person              Date 
Consent                                                 Administering Consent 
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Appendix D9 
Informed Consent 
 
IRC Approved: 09/10/2010  
Last Approval: 09/10/2010  
Expires: 09/09/2011 
 
I, the undersigned, certify that to the best of my knowledge, the subject/legal 
representative signing this consent had the study fully and carefully explained. He/she 
clearly understands the nature, risks and benefits of participation in this process. 
 
 
_______________________________ ___________________  
Signature of Investigator/Designee Date 
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Appendix E 
Demographic Form 
 
 
-1- 
 
DEMOGRAPHIC FORM 
 
Have you been diagnosed 
with Heart Failure? 
YES           NO 
How long have you had 
Heart Failure? 
 
                      (years/months) 
How long have you been 
participating at the Heart 
Failure Clinic? 
 
 
                      (years/months) 
Age                             (years) 
Gender MALE          FEMALE 
Ethnicity  Caucasian 
 African American 
 Hispanic 
 Asian 
 Other 
Appendix F 
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Self-Care of Heart Failure Index 
 
-1- 
SELF-CARE OF HEART FAILURE INDEX  
All answers are confidential. 
 
Think about how you have been feeling in the last month or since we last spoke as 
you complete these items.  
 
SECTION A: 
Listed below are common instructions given to persons with heart failure. How routinely 
do you do the following? 
 
 
 
 
 
Appendix G 
 Never or 
rarely 
Sometimes Frequently Always 
or daily 
1. Weigh yourself? 1 2 3 4 
2. Check your ankles for swelling? 1 2 3 4 
3. Try to avoid getting sick (e.g., flu shot, 
avoid ill people)? 
1 2 3 4 
4. Do some physical activity? 1 2 3 4 
5. Keep doctor or nurse appointments? 1 2 3 4 
6. Eat a low salt diet? 1 2 3 4 
7. Exercise for 30 minutes? 1 2 3 4 
8. Forget to take one of your medicines? 1 2 3 4 
9. Ask for low salt items when eating out or 
visiting others? 
1 2 3 4 
10. Use a system (pill box, reminders) to help 
you remember your medicines? 
1 2 3 4 
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Minnesota Living with Heart Failure Questionnaire 
 
-1- 
 
 
Appendix H1 
11/10/04 
 
 
 
MINNESOTA LIVING WITH HEART FAILURE! QUESTIONNAIRE 
 
The following questions ask how much your heart failure (heart condition) affected your 
life during the past month (4 weeks).  After each question, circle the 0, 1, 2, 3, 4 or 5 to 
show how much your life was affected.  If a question does not apply to you, circle the 0 
after that question. 
 
Did your heart failure prevent  
you from living as you wanted during                        Very                            Very 
the past month (4 weeks) by -                          No      Little                 Much  
       
1.  causing swelling in your ankles or legs?           0            1        2        3        4        5 
2.  making you sit or lie down to rest during    
     the day?                    0            1        2        3        4        5 
3.  making your walking about or climbing      
     stairs difficult?                   0            1        2        3        4        5 
4.  making your working around the house    
     or yard difficult?                   0            1        2        3        4        5 
5.  making your going places away from           
     home difficult?                   0            1        2        3        4        5 
6.  making your sleeping well at night 
     difficult?                    0            1        2        3        4        5 
7.  making your relating to or doing things 
     with your friends or family difficult?                0            1        2        3        4        5 
8.  making your working to earn a living 
     difficult?                    0            1        2        3        4        5                                                               
9.  making your recreational pastimes, sports 
     or hobbies difficult?                  0            1        2        3        4        5 
10.  making your sexual activities difficult?    0            1        2        3        4        5 
11.  making you eat less of the foods you  
        like?                    0            1        2        3        4        5 
12.  making you short of breath?                 0            1        2        3        4        5 
13.  making you tired, fatigued, or low on 
       energy?                    0            1        2        3        4        5 
14.  making you stay in a hospital?     0            1        2        3        4        5 
15.  costing you money for medical care?    0            1        2        3        4        5 
16.  giving you side effects from treatments?    0            1        2        3        4        5   
17.  making you feel you are a burden to your  
       family or friends?          0            1        2        3        4        5 
18.  making you feel a loss of self-control 
        in your life?                   0            1        2        3        4        5  
19.  making you worry?                  0            1        2        3        4        5 
20.  making it difficult for you to concentrate 
        or remember things?                  0            1        2        3        4        5  
21.  making you feel depressed?                 0            1        2        3        4        5 
_________________________________________________________________________ 
 
©1986 Regents of the University of Minnesota, All rights reserved.  Do not copy or reproduce without permission. 
LIVING WITH HEART FAILURE® is a registered trademark of the Regents of the University of Minnesota. 
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Minnesota Living with Heart Failure Questionnaire Permission for Use 
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Minnesota Living with Heart Failure 
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Minnesota Living with Heart Failure 
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Appendix I1 
Heart Failure Diary 
 
Sunday Weight (lbs): 
Weight (lbs) 
Loss (-) OR Gain (+) 
Weight                                                                                                    Weight 
Loss                                                                                                         Gain 
Fluid Intake No                                                                                                            Lots of 
Fluid                                                                                                           Fluid 
Salt Intake No                                                                                                            Lots of 
Salt                                                                                                             Salt 
Shortness of Breath 
(SOB) 
No                                                                                                              Very  
SOB                                                                                                            SOB 
Swelling No                                                                                                            Lots of 
Swelling                                                                                                Swelling 
Taking Medication No                                                                                                               All 
Meds                                                                                                          Meds 
Monday Weight (lbs): 
Weight (lbs) 
Loss (-) OR Gain (+) 
Weight                                                                                                    Weight 
Loss                                                                                                         Gain 
Fluid Intake No                                                                                                            Lots of 
Fluid                                                                                                           Fluid 
Salt Intake No                                                                                                            Lots of 
Salt                                                                                                             Salt 
Shortness of Breath 
(SOB) 
No                                                                                                              Very  
SOB                                                                                                            SOB 
Swelling No                                                                                                            Lots of 
Swelling                                                                                                Swelling 
Taking Medication No                              All
Meds                                                                                                          Meds 
-5        -4        -3        -2         -1        0        +1       
-5        -4        -3        -2         -1        0        +1       
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Appendix I2 
Heart Failure Diary 
 
 
 Sunday Weight – Saturday Weight = TOTAL        (gain OR loss) 
Total           GAIN (+) 
Total           LOSS (-) 
NOTES  
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Appendix J   
Evaluation Form 
 
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
The Baptist Medical Center Heart Failure: 
A Patient Guide book used for education 
was appropriate 
     
The individual education was informative      
I felt comfortable asking questions and 
verbalizing concerns 
     
I understand Heart Failure BETTER now 
than before participation in the study  
     
The Heart Failure Diary was simple to use      
Using a Heart Failure Diary is very 
beneficial in keeping track of my weight 
and symptoms 
     
I will continue to use the Heart Failure 
Diary 
     
All of the forms were easy to read       
All of the forms were easy to understand      
Participating in the study made a 
difference in how I care for myself 
     
The student researcher was informative      
The student researcher was accessible      
The student researcher was organized      
	   Comments:	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Appendix K  
Heart Failure: A Patient Guide Book 
 
 
 
 
Heart Failure:
A Patient Guidebook
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Appendix L   
Master List 
 
Master List 
 
PARTICIPANT CODE # NAME PHONE NUMBER 
1   
2   
3   
4   
5   
6   
7   
8   
9   
10   
11   
12   
13   
14   
15   
16   
17   
18   
19   
20   
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